PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Sp1
|
ENSMUSG00000001280.14 | Sp1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Sp1 | mm39_v1_chr15_+_102315579_102315704 | -0.15 | 2.0e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chrX_+_7504913 | 20.82 |
ENSMUST00000128890.2
|
Syp
|
synaptophysin |
chr9_+_110075133 | 20.21 |
ENSMUST00000199736.2
|
Cspg5
|
chondroitin sulfate proteoglycan 5 |
chr9_+_110074574 | 17.85 |
ENSMUST00000197850.5
|
Cspg5
|
chondroitin sulfate proteoglycan 5 |
chr6_+_115111872 | 17.12 |
ENSMUST00000009538.12
ENSMUST00000203450.2 |
Syn2
|
synapsin II |
chr1_-_168259710 | 16.47 |
ENSMUST00000072863.6
|
Pbx1
|
pre B cell leukemia homeobox 1 |
chr7_-_127423641 | 16.36 |
ENSMUST00000106267.5
|
Stx1b
|
syntaxin 1B |
chr2_-_130484689 | 15.97 |
ENSMUST00000045761.7
|
Lzts3
|
leucine zipper, putative tumor suppressor family member 3 |
chr11_-_69728560 | 15.81 |
ENSMUST00000108634.9
|
Nlgn2
|
neuroligin 2 |
chr15_+_89383799 | 15.76 |
ENSMUST00000109309.9
|
Shank3
|
SH3 and multiple ankyrin repeat domains 3 |
chr9_+_21848282 | 15.48 |
ENSMUST00000046371.13
|
Plppr2
|
phospholipid phosphatase related 2 |
chr11_+_78213791 | 15.47 |
ENSMUST00000017534.15
|
Aldoc
|
aldolase C, fructose-bisphosphate |
chr15_+_80057894 | 15.46 |
ENSMUST00000044970.7
|
Mgat3
|
mannoside acetylglucosaminyltransferase 3 |
chr15_+_76544058 | 15.38 |
ENSMUST00000230451.2
|
Kifc2
|
kinesin family member C2 |
chr6_+_115111860 | 15.29 |
ENSMUST00000169345.4
|
Syn2
|
synapsin II |
chr11_-_101917745 | 15.24 |
ENSMUST00000107167.2
ENSMUST00000062801.11 |
Mpp3
|
membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3) |
chr19_-_4993060 | 14.89 |
ENSMUST00000133504.2
ENSMUST00000133254.2 ENSMUST00000120475.8 ENSMUST00000025834.15 |
Peli3
|
pellino 3 |
chr13_-_55635851 | 14.65 |
ENSMUST00000109921.9
ENSMUST00000109923.9 ENSMUST00000021950.15 |
Dbn1
|
drebrin 1 |
chr7_+_29991101 | 14.60 |
ENSMUST00000150892.2
ENSMUST00000126216.2 ENSMUST00000014065.16 |
Clip3
|
CAP-GLY domain containing linker protein 3 |
chr1_-_75240551 | 14.48 |
ENSMUST00000186178.7
ENSMUST00000189769.7 ENSMUST00000027404.12 |
Ptprn
|
protein tyrosine phosphatase, receptor type, N |
chr9_+_109760856 | 14.43 |
ENSMUST00000169851.8
|
Map4
|
microtubule-associated protein 4 |
chr2_+_164802766 | 14.43 |
ENSMUST00000202223.4
|
Slc12a5
|
solute carrier family 12, member 5 |
chr1_-_172034251 | 14.39 |
ENSMUST00000155109.2
|
Pea15a
|
phosphoprotein enriched in astrocytes 15A |
chr15_-_103446354 | 14.34 |
ENSMUST00000023133.8
|
Ppp1r1a
|
protein phosphatase 1, regulatory inhibitor subunit 1A |
chr2_+_164802729 | 14.28 |
ENSMUST00000202623.4
|
Slc12a5
|
solute carrier family 12, member 5 |
chr12_+_108300599 | 14.23 |
ENSMUST00000021684.6
|
Cyp46a1
|
cytochrome P450, family 46, subfamily a, polypeptide 1 |
chr1_-_168259839 | 14.16 |
ENSMUST00000188912.7
|
Pbx1
|
pre B cell leukemia homeobox 1 |
chr15_-_75438660 | 13.70 |
ENSMUST00000065417.15
|
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr11_+_69909245 | 13.48 |
ENSMUST00000231415.2
ENSMUST00000108588.9 |
Dlg4
|
discs large MAGUK scaffold protein 4 |
chrX_-_159777661 | 13.44 |
ENSMUST00000087104.11
|
Cdkl5
|
cyclin-dependent kinase-like 5 |
chr7_-_45016138 | 13.25 |
ENSMUST00000211067.2
ENSMUST00000003961.16 |
Ppfia3
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 |
chr4_-_129015493 | 13.17 |
ENSMUST00000135763.2
ENSMUST00000149763.3 ENSMUST00000164649.8 |
Hpca
|
hippocalcin |
chr14_-_100522101 | 13.07 |
ENSMUST00000228216.2
|
Klf12
|
Kruppel-like factor 12 |
chr7_+_24181416 | 13.06 |
ENSMUST00000068023.8
|
Cadm4
|
cell adhesion molecule 4 |
chr7_-_105282687 | 13.02 |
ENSMUST00000147044.4
ENSMUST00000106791.8 ENSMUST00000153371.9 ENSMUST00000106789.8 |
Trim3
|
tripartite motif-containing 3 |
chr1_-_135302971 | 13.01 |
ENSMUST00000041240.4
|
Shisa4
|
shisa family member 4 |
chr5_+_37399284 | 12.91 |
ENSMUST00000202434.4
ENSMUST00000114158.9 |
Crmp1
|
collapsin response mediator protein 1 |
chr1_-_77491683 | 12.83 |
ENSMUST00000186930.2
ENSMUST00000027451.13 ENSMUST00000188797.7 |
Epha4
|
Eph receptor A4 |
chr14_-_20844034 | 12.83 |
ENSMUST00000226630.2
|
Camk2g
|
calcium/calmodulin-dependent protein kinase II gamma |
chr7_-_100581314 | 12.78 |
ENSMUST00000107032.3
|
Arhgef17
|
Rho guanine nucleotide exchange factor (GEF) 17 |
chr15_-_75439013 | 12.77 |
ENSMUST00000156032.2
ENSMUST00000127095.8 |
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr15_+_32244947 | 12.76 |
ENSMUST00000067458.7
|
Sema5a
|
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
chr17_+_26028059 | 12.71 |
ENSMUST00000045692.9
|
Fbxl16
|
F-box and leucine-rich repeat protein 16 |
chr1_-_168259465 | 12.60 |
ENSMUST00000176540.8
|
Pbx1
|
pre B cell leukemia homeobox 1 |
chr17_-_57394718 | 12.45 |
ENSMUST00000071135.6
|
Tubb4a
|
tubulin, beta 4A class IVA |
chr19_+_6547790 | 12.44 |
ENSMUST00000113458.8
ENSMUST00000113459.2 |
Nrxn2
|
neurexin II |
chr7_+_19016536 | 12.39 |
ENSMUST00000032559.17
|
Rtn2
|
reticulon 2 (Z-band associated protein) |
chr7_-_143014726 | 12.32 |
ENSMUST00000167912.9
ENSMUST00000037287.8 |
Cdkn1c
|
cyclin-dependent kinase inhibitor 1C (P57) |
chr17_-_56769193 | 12.14 |
ENSMUST00000086828.10
|
Ptprs
|
protein tyrosine phosphatase, receptor type, S |
chr11_-_102837514 | 12.12 |
ENSMUST00000057849.6
|
C1ql1
|
complement component 1, q subcomponent-like 1 |
chr2_+_76236870 | 12.10 |
ENSMUST00000077972.11
ENSMUST00000111929.8 ENSMUST00000111930.9 |
Osbpl6
|
oxysterol binding protein-like 6 |
chr10_+_81068980 | 12.08 |
ENSMUST00000144087.2
ENSMUST00000117798.8 |
Zfr2
|
zinc finger RNA binding protein 2 |
chr12_-_4891435 | 12.03 |
ENSMUST00000219880.2
ENSMUST00000020964.7 |
Fkbp1b
|
FK506 binding protein 1b |
chr7_+_3381434 | 11.97 |
ENSMUST00000092891.6
|
Cacng7
|
calcium channel, voltage-dependent, gamma subunit 7 |
chr2_-_32737208 | 11.97 |
ENSMUST00000077458.7
ENSMUST00000208840.2 |
Stxbp1
|
syntaxin binding protein 1 |
chr15_-_75438457 | 11.96 |
ENSMUST00000163116.8
ENSMUST00000023241.12 |
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr12_-_84497718 | 11.88 |
ENSMUST00000085192.7
ENSMUST00000220491.2 |
Aldh6a1
|
aldehyde dehydrogenase family 6, subfamily A1 |
chr1_+_74894069 | 11.88 |
ENSMUST00000160379.4
|
Cdk5r2
|
cyclin-dependent kinase 5, regulatory subunit 2 (p39) |
chr2_+_97298002 | 11.87 |
ENSMUST00000059049.8
|
Lrrc4c
|
leucine rich repeat containing 4C |
chr3_+_96088467 | 11.77 |
ENSMUST00000035371.9
|
Sv2a
|
synaptic vesicle glycoprotein 2 a |
chr8_-_65186565 | 11.76 |
ENSMUST00000141021.2
|
Msmo1
|
methylsterol monoxygenase 1 |
chr18_-_38345010 | 11.72 |
ENSMUST00000159405.3
ENSMUST00000160721.8 |
Pcdh1
|
protocadherin 1 |
chr11_+_119833589 | 11.69 |
ENSMUST00000106231.8
ENSMUST00000075180.12 ENSMUST00000103021.10 ENSMUST00000026436.10 ENSMUST00000106233.2 |
Baiap2
|
brain-specific angiogenesis inhibitor 1-associated protein 2 |
chr10_-_127098932 | 11.63 |
ENSMUST00000217895.2
|
Kif5a
|
kinesin family member 5A |
chr1_-_172034354 | 11.62 |
ENSMUST00000013842.12
ENSMUST00000111247.8 |
Pea15a
|
phosphoprotein enriched in astrocytes 15A |
chr13_+_104246245 | 11.60 |
ENSMUST00000044385.14
|
Sgtb
|
small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta |
chr10_-_80850712 | 11.55 |
ENSMUST00000126317.2
ENSMUST00000092285.10 ENSMUST00000117805.8 |
Gng7
|
guanine nucleotide binding protein (G protein), gamma 7 |
chr9_+_106331041 | 11.51 |
ENSMUST00000024260.14
ENSMUST00000216379.2 ENSMUST00000215656.2 ENSMUST00000214252.2 |
Pcbp4
|
poly(rC) binding protein 4 |
chr4_-_156281935 | 11.51 |
ENSMUST00000180572.2
|
Agrn
|
agrin |
chr6_-_24956296 | 11.46 |
ENSMUST00000127247.4
|
Tmem229a
|
transmembrane protein 229A |
chr3_-_107366868 | 11.38 |
ENSMUST00000009617.10
ENSMUST00000238670.2 |
Kcnc4
|
potassium voltage gated channel, Shaw-related subfamily, member 4 |
chr19_+_4560500 | 11.25 |
ENSMUST00000068004.13
ENSMUST00000224726.3 |
Pcx
|
pyruvate carboxylase |
chr9_-_20657643 | 11.17 |
ENSMUST00000215999.2
|
Olfm2
|
olfactomedin 2 |
chr8_-_105122397 | 11.07 |
ENSMUST00000179802.2
|
Cmtm4
|
CKLF-like MARVEL transmembrane domain containing 4 |
chr11_-_115167775 | 10.97 |
ENSMUST00000021078.3
|
Fdxr
|
ferredoxin reductase |
chr15_+_76544763 | 10.95 |
ENSMUST00000004294.12
|
Kifc2
|
kinesin family member C2 |
chr9_+_50664207 | 10.89 |
ENSMUST00000034562.9
|
Cryab
|
crystallin, alpha B |
chr15_+_81695615 | 10.85 |
ENSMUST00000023024.8
|
Tef
|
thyrotroph embryonic factor |
chr7_-_30144933 | 10.82 |
ENSMUST00000006828.9
|
Aplp1
|
amyloid beta (A4) precursor-like protein 1 |
chr2_+_31135813 | 10.76 |
ENSMUST00000000199.8
|
Ncs1
|
neuronal calcium sensor 1 |
chr1_-_93029532 | 10.75 |
ENSMUST00000171796.8
|
Kif1a
|
kinesin family member 1A |
chr5_-_37146266 | 10.75 |
ENSMUST00000166339.8
|
Wfs1
|
wolframin ER transmembrane glycoprotein |
chrX_-_94209913 | 10.72 |
ENSMUST00000113873.9
ENSMUST00000113876.9 ENSMUST00000199920.5 ENSMUST00000113885.8 ENSMUST00000113883.8 ENSMUST00000196012.2 ENSMUST00000182001.8 ENSMUST00000113878.8 ENSMUST00000113882.8 ENSMUST00000182562.2 |
Arhgef9
|
CDC42 guanine nucleotide exchange factor (GEF) 9 |
chrX_+_80114242 | 10.70 |
ENSMUST00000171953.8
ENSMUST00000026760.3 |
Tmem47
|
transmembrane protein 47 |
chr13_+_104246259 | 10.69 |
ENSMUST00000160322.8
ENSMUST00000159574.2 |
Sgtb
|
small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta |
chr1_-_88629843 | 10.67 |
ENSMUST00000159814.2
|
Arl4c
|
ADP-ribosylation factor-like 4C |
chr2_-_113659360 | 10.64 |
ENSMUST00000024005.8
|
Scg5
|
secretogranin V |
chr14_-_52151537 | 10.63 |
ENSMUST00000227402.2
ENSMUST00000227237.2 |
Ndrg2
|
N-myc downstream regulated gene 2 |
chr2_-_32737238 | 10.45 |
ENSMUST00000050000.16
|
Stxbp1
|
syntaxin binding protein 1 |
chr16_-_20440005 | 10.43 |
ENSMUST00000052939.4
|
Camk2n2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2 |
chr13_+_54937312 | 10.40 |
ENSMUST00000163915.8
ENSMUST00000099503.10 ENSMUST00000171859.8 |
Tspan17
|
tetraspanin 17 |
chrX_+_150927237 | 10.31 |
ENSMUST00000168786.8
ENSMUST00000112605.8 ENSMUST00000112604.8 |
Iqsec2
|
IQ motif and Sec7 domain 2 |
chr10_+_40759468 | 10.23 |
ENSMUST00000019975.14
|
Wasf1
|
WASP family, member 1 |
chr5_+_33879018 | 10.21 |
ENSMUST00000201437.4
ENSMUST00000067150.14 ENSMUST00000169212.9 ENSMUST00000114411.9 ENSMUST00000164207.10 ENSMUST00000087820.8 |
Fgfr3
|
fibroblast growth factor receptor 3 |
chr5_-_38316706 | 10.20 |
ENSMUST00000201341.2
ENSMUST00000201363.4 ENSMUST00000201134.2 |
Nsg1
|
neuron specific gene family member 1 |
chr7_-_105217851 | 10.16 |
ENSMUST00000188368.7
ENSMUST00000187057.7 |
Apbb1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 |
chr17_-_64638814 | 10.09 |
ENSMUST00000172733.2
|
Pja2
|
praja ring finger ubiquitin ligase 2 |
chr7_+_128213084 | 10.02 |
ENSMUST00000043138.13
|
Inpp5f
|
inositol polyphosphate-5-phosphatase F |
chr1_+_75358758 | 10.01 |
ENSMUST00000148515.8
ENSMUST00000113590.8 |
Speg
|
SPEG complex locus |
chr9_-_107586678 | 9.99 |
ENSMUST00000193108.6
|
Sema3f
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr17_-_64638887 | 9.97 |
ENSMUST00000172818.8
|
Pja2
|
praja ring finger ubiquitin ligase 2 |
chr11_+_98632696 | 9.94 |
ENSMUST00000103139.11
|
Thra
|
thyroid hormone receptor alpha |
chr17_+_24707711 | 9.94 |
ENSMUST00000024958.9
ENSMUST00000234717.2 |
Caskin1
|
CASK interacting protein 1 |
chr19_+_6468761 | 9.93 |
ENSMUST00000113462.8
ENSMUST00000077182.13 ENSMUST00000236635.2 ENSMUST00000113461.8 |
Nrxn2
|
neurexin II |
chr17_-_45996899 | 9.89 |
ENSMUST00000145873.8
|
Tmem63b
|
transmembrane protein 63b |
chr16_+_20551853 | 9.89 |
ENSMUST00000115423.8
ENSMUST00000007171.13 ENSMUST00000232646.2 |
Chrd
|
chordin |
chr7_+_44240310 | 9.81 |
ENSMUST00000107906.6
|
Kcnc3
|
potassium voltage gated channel, Shaw-related subfamily, member 3 |
chr17_-_57366795 | 9.79 |
ENSMUST00000040280.14
|
Slc25a23
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23 |
chr5_-_38316296 | 9.75 |
ENSMUST00000201415.4
|
Nsg1
|
neuron specific gene family member 1 |
chr8_+_106245368 | 9.66 |
ENSMUST00000034363.7
|
Hsd11b2
|
hydroxysteroid 11-beta dehydrogenase 2 |
chr10_+_40759815 | 9.66 |
ENSMUST00000105509.2
|
Wasf1
|
WASP family, member 1 |
chr15_-_37792237 | 9.64 |
ENSMUST00000168992.8
ENSMUST00000148652.9 |
Ncald
|
neurocalcin delta |
chr11_+_90140252 | 9.64 |
ENSMUST00000107887.8
|
Mmd
|
monocyte to macrophage differentiation-associated |
chr5_+_16139683 | 9.63 |
ENSMUST00000167946.9
|
Cacna2d1
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
chr4_-_117740624 | 9.63 |
ENSMUST00000030266.12
|
B4galt2
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 |
chr4_+_138181616 | 9.62 |
ENSMUST00000050918.4
|
Camk2n1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr2_+_157401998 | 9.59 |
ENSMUST00000153739.9
ENSMUST00000173595.2 ENSMUST00000109526.2 ENSMUST00000173839.2 ENSMUST00000173041.8 ENSMUST00000173793.8 ENSMUST00000172487.2 ENSMUST00000088484.6 |
Nnat
|
neuronatin |
chr7_+_26958150 | 9.58 |
ENSMUST00000079258.7
|
Numbl
|
numb-like |
chr2_+_136555364 | 9.52 |
ENSMUST00000028727.11
ENSMUST00000110098.4 |
Snap25
|
synaptosomal-associated protein 25 |
chr7_-_105282751 | 9.49 |
ENSMUST00000057525.14
|
Trim3
|
tripartite motif-containing 3 |
chr9_-_86762467 | 9.46 |
ENSMUST00000074501.12
ENSMUST00000239074.2 ENSMUST00000098495.10 ENSMUST00000036347.13 ENSMUST00000074468.13 |
Snap91
|
synaptosomal-associated protein 91 |
chr13_+_42862957 | 9.45 |
ENSMUST00000066928.12
ENSMUST00000148891.8 |
Phactr1
|
phosphatase and actin regulator 1 |
chr10_-_127456791 | 9.44 |
ENSMUST00000118455.2
ENSMUST00000121829.8 |
Lrp1
|
low density lipoprotein receptor-related protein 1 |
chr13_+_54937190 | 9.42 |
ENSMUST00000026993.14
ENSMUST00000131692.9 ENSMUST00000163796.8 |
Tspan17
|
tetraspanin 17 |
chr2_-_73216743 | 9.40 |
ENSMUST00000112044.8
ENSMUST00000112043.8 ENSMUST00000076463.12 |
Gpr155
|
G protein-coupled receptor 155 |
chr8_+_71207326 | 9.38 |
ENSMUST00000110093.9
ENSMUST00000143118.3 ENSMUST00000034301.12 ENSMUST00000110090.8 |
Rab3a
|
RAB3A, member RAS oncogene family |
chr2_+_174602412 | 9.37 |
ENSMUST00000029030.9
|
Edn3
|
endothelin 3 |
chr14_+_121272606 | 9.37 |
ENSMUST00000135010.8
|
Farp1
|
FERM, RhoGEF (Arhgef) and pleckstrin domain protein 1 (chondrocyte-derived) |
chr8_+_94537460 | 9.33 |
ENSMUST00000034198.15
ENSMUST00000125716.8 |
Gnao1
|
guanine nucleotide binding protein, alpha O |
chr5_+_137551774 | 9.25 |
ENSMUST00000136088.8
ENSMUST00000139395.8 |
Actl6b
|
actin-like 6B |
chr6_+_17281303 | 9.23 |
ENSMUST00000115459.2
ENSMUST00000115462.2 |
Cav2
|
caveolin 2 |
chr14_+_121272950 | 9.23 |
ENSMUST00000026635.8
|
Farp1
|
FERM, RhoGEF (Arhgef) and pleckstrin domain protein 1 (chondrocyte-derived) |
chr2_-_167030706 | 9.17 |
ENSMUST00000207917.2
|
Kcnb1
|
potassium voltage gated channel, Shab-related subfamily, member 1 |
chr4_-_68872585 | 9.13 |
ENSMUST00000030036.6
|
Brinp1
|
bone morphogenic protein/retinoic acid inducible neural specific 1 |
chr1_+_88998115 | 9.10 |
ENSMUST00000066279.11
|
Sh3bp4
|
SH3-domain binding protein 4 |
chr6_+_49799690 | 9.09 |
ENSMUST00000031843.7
|
Npy
|
neuropeptide Y |
chrX_+_72716756 | 9.06 |
ENSMUST00000033752.14
ENSMUST00000114467.9 |
Slc6a8
|
solute carrier family 6 (neurotransmitter transporter, creatine), member 8 |
chr15_-_74624811 | 9.04 |
ENSMUST00000189128.2
ENSMUST00000023259.15 |
Lynx1
|
Ly6/neurotoxin 1 |
chr9_-_95632387 | 9.04 |
ENSMUST00000189137.7
ENSMUST00000053785.10 |
Trpc1
|
transient receptor potential cation channel, subfamily C, member 1 |
chr4_+_137434767 | 9.02 |
ENSMUST00000097837.11
|
Rap1gap
|
Rap1 GTPase-activating protein |
chr9_-_44632680 | 9.01 |
ENSMUST00000148929.2
ENSMUST00000123406.8 |
Phldb1
|
pleckstrin homology like domain, family B, member 1 |
chr17_+_27160356 | 9.00 |
ENSMUST00000229490.2
ENSMUST00000201702.5 ENSMUST00000177932.7 ENSMUST00000201349.6 |
Syngap1
|
synaptic Ras GTPase activating protein 1 homolog (rat) |
chr11_-_94967623 | 8.99 |
ENSMUST00000145671.2
ENSMUST00000120375.8 |
Itga3
|
integrin alpha 3 |
chr12_+_116449419 | 8.94 |
ENSMUST00000070733.9
|
Ptprn2
|
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
chr11_-_61470462 | 8.93 |
ENSMUST00000147501.8
ENSMUST00000146455.8 ENSMUST00000108711.8 ENSMUST00000108712.8 ENSMUST00000001063.15 ENSMUST00000108713.8 ENSMUST00000179936.8 ENSMUST00000178202.8 |
Epn2
|
epsin 2 |
chr11_+_120612369 | 8.87 |
ENSMUST00000142229.2
|
Rac3
|
Rac family small GTPase 3 |
chr2_+_25293140 | 8.86 |
ENSMUST00000154809.8
ENSMUST00000055921.14 ENSMUST00000141567.8 |
Npdc1
|
neural proliferation, differentiation and control 1 |
chr7_+_16609227 | 8.85 |
ENSMUST00000108493.3
|
Dact3
|
dishevelled-binding antagonist of beta-catenin 3 |
chr17_+_37357451 | 8.84 |
ENSMUST00000172789.2
|
Gabbr1
|
gamma-aminobutyric acid (GABA) B receptor, 1 |
chr9_-_108140925 | 8.78 |
ENSMUST00000171412.7
ENSMUST00000195429.6 ENSMUST00000080435.9 |
Dag1
|
dystroglycan 1 |
chr1_-_93029547 | 8.78 |
ENSMUST00000112958.9
ENSMUST00000186861.2 ENSMUST00000171556.8 |
Kif1a
|
kinesin family member 1A |
chr11_+_98632631 | 8.77 |
ENSMUST00000064187.12
|
Thra
|
thyroid hormone receptor alpha |
chr3_-_88679881 | 8.77 |
ENSMUST00000090945.5
|
Syt11
|
synaptotagmin XI |
chr11_-_94967483 | 8.70 |
ENSMUST00000001548.14
|
Itga3
|
integrin alpha 3 |
chr2_+_156317416 | 8.70 |
ENSMUST00000029155.16
|
Epb41l1
|
erythrocyte membrane protein band 4.1 like 1 |
chr5_-_139115914 | 8.70 |
ENSMUST00000129851.8
|
Prkar1b
|
protein kinase, cAMP dependent regulatory, type I beta |
chr7_-_126620249 | 8.69 |
ENSMUST00000202045.2
|
Prrt2
|
proline-rich transmembrane protein 2 |
chr7_-_118594365 | 8.66 |
ENSMUST00000008878.10
|
Gprc5b
|
G protein-coupled receptor, family C, group 5, member B |
chr7_-_16348862 | 8.66 |
ENSMUST00000171937.2
ENSMUST00000075845.11 |
Arhgap35
|
Rho GTPase activating protein 35 |
chr3_+_156267429 | 8.66 |
ENSMUST00000074015.11
|
Negr1
|
neuronal growth regulator 1 |
chr15_-_99425555 | 8.65 |
ENSMUST00000231171.2
|
Faim2
|
Fas apoptotic inhibitory molecule 2 |
chr10_-_127099183 | 8.60 |
ENSMUST00000099172.5
|
Kif5a
|
kinesin family member 5A |
chr13_-_17869314 | 8.57 |
ENSMUST00000221598.2
ENSMUST00000068545.6 ENSMUST00000220514.2 |
Sugct
|
succinyl-CoA glutarate-CoA transferase |
chr14_-_52516695 | 8.56 |
ENSMUST00000167116.8
ENSMUST00000100631.11 |
Rab2b
|
RAB2B, member RAS oncogene family |
chr7_-_16019935 | 8.54 |
ENSMUST00000145519.3
|
Ccdc9
|
coiled-coil domain containing 9 |
chrX_-_149596680 | 8.52 |
ENSMUST00000112700.8
|
Maged2
|
MAGE family member D2 |
chr4_-_126647156 | 8.50 |
ENSMUST00000030637.14
ENSMUST00000106116.2 |
Ncdn
|
neurochondrin |
chr10_+_86136236 | 8.42 |
ENSMUST00000020234.14
|
Timp3
|
tissue inhibitor of metalloproteinase 3 |
chr9_+_47441471 | 8.41 |
ENSMUST00000114548.8
ENSMUST00000152459.8 ENSMUST00000143026.9 ENSMUST00000085909.9 ENSMUST00000114547.8 ENSMUST00000239368.2 ENSMUST00000214542.2 ENSMUST00000034581.4 |
Cadm1
|
cell adhesion molecule 1 |
chr11_+_101358990 | 8.41 |
ENSMUST00000001347.7
|
Rnd2
|
Rho family GTPase 2 |
chr11_+_120612278 | 8.40 |
ENSMUST00000018156.12
|
Rac3
|
Rac family small GTPase 3 |
chr5_+_135052336 | 8.30 |
ENSMUST00000005509.11
ENSMUST00000201008.4 |
Stx1a
|
syntaxin 1A (brain) |
chr2_-_37249208 | 8.24 |
ENSMUST00000147703.3
|
Pdcl
|
phosducin-like |
chr15_+_84052028 | 8.24 |
ENSMUST00000045289.6
|
Pnpla3
|
patatin-like phospholipase domain containing 3 |
chr7_+_44813363 | 8.23 |
ENSMUST00000085374.7
ENSMUST00000209634.2 |
Slc17a7
|
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7 |
chr7_-_4550523 | 8.22 |
ENSMUST00000206023.2
|
Syt5
|
synaptotagmin V |
chr17_+_87415049 | 8.21 |
ENSMUST00000041369.8
ENSMUST00000234803.2 |
Socs5
|
suppressor of cytokine signaling 5 |
chr10_-_127370408 | 8.17 |
ENSMUST00000095266.3
|
Nxph4
|
neurexophilin 4 |
chr10_+_98750268 | 8.16 |
ENSMUST00000219557.2
|
Atp2b1
|
ATPase, Ca++ transporting, plasma membrane 1 |
chr7_-_138768374 | 8.14 |
ENSMUST00000016125.12
|
Stk32c
|
serine/threonine kinase 32C |
chr12_+_105420089 | 8.14 |
ENSMUST00000178224.2
|
D430019H16Rik
|
RIKEN cDNA D430019H16 gene |
chr7_-_126620378 | 8.12 |
ENSMUST00000159916.5
|
Prrt2
|
proline-rich transmembrane protein 2 |
chr4_-_133225849 | 8.11 |
ENSMUST00000125541.2
|
Trnp1
|
TMF1-regulated nuclear protein 1 |
chr19_-_5148506 | 8.10 |
ENSMUST00000025805.8
|
Cnih2
|
cornichon family AMPA receptor auxiliary protein 2 |
chr15_-_91457383 | 8.08 |
ENSMUST00000109283.2
|
Slc2a13
|
solute carrier family 2 (facilitated glucose transporter), member 13 |
chrX_+_149830166 | 8.07 |
ENSMUST00000026296.8
|
Fgd1
|
FYVE, RhoGEF and PH domain containing 1 |
chr15_+_54434576 | 8.04 |
ENSMUST00000025356.4
|
Mal2
|
mal, T cell differentiation protein 2 |
chr5_-_139115417 | 8.02 |
ENSMUST00000026973.14
|
Prkar1b
|
protein kinase, cAMP dependent regulatory, type I beta |
chrX_-_46981379 | 7.99 |
ENSMUST00000077569.11
ENSMUST00000101616.9 ENSMUST00000088973.11 |
Smarca1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 |
chr15_+_89384317 | 7.98 |
ENSMUST00000135214.2
|
Shank3
|
SH3 and multiple ankyrin repeat domains 3 |
chr1_+_182591425 | 7.97 |
ENSMUST00000155229.7
ENSMUST00000153348.8 |
Susd4
|
sushi domain containing 4 |
chr15_-_75963446 | 7.97 |
ENSMUST00000228366.3
|
Nrbp2
|
nuclear receptor binding protein 2 |
chr7_-_105230395 | 7.96 |
ENSMUST00000188726.2
ENSMUST00000188440.7 |
Apbb1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 |
chr9_+_107812873 | 7.95 |
ENSMUST00000035700.14
|
Camkv
|
CaM kinase-like vesicle-associated |
chr5_+_35915217 | 7.94 |
ENSMUST00000101280.10
ENSMUST00000054598.12 ENSMUST00000114205.8 ENSMUST00000114206.9 |
Ablim2
|
actin-binding LIM protein 2 |
chr2_+_121697398 | 7.93 |
ENSMUST00000110586.10
ENSMUST00000078752.10 |
Golm2
|
golgi membrane protein 2 |
chr6_-_124745294 | 7.92 |
ENSMUST00000135626.8
|
Eno2
|
enolase 2, gamma neuronal |
chr12_+_44375665 | 7.91 |
ENSMUST00000110748.4
|
Nrcam
|
neuronal cell adhesion molecule |
chr3_-_89152320 | 7.90 |
ENSMUST00000107464.8
ENSMUST00000090924.13 |
Trim46
|
tripartite motif-containing 46 |
chr4_-_141966662 | 7.88 |
ENSMUST00000036476.10
|
Kazn
|
kazrin, periplakin interacting protein |
chrX_-_9529189 | 7.87 |
ENSMUST00000033519.3
|
Dynlt3
|
dynein light chain Tctex-type 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.9 | 29.7 | GO:0040040 | thermosensory behavior(GO:0040040) |
7.1 | 21.2 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
7.0 | 35.0 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
6.6 | 39.3 | GO:0050758 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
6.3 | 6.3 | GO:1901678 | iron coordination entity transport(GO:1901678) |
6.1 | 18.3 | GO:0001966 | thigmotaxis(GO:0001966) |
6.1 | 24.4 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
6.0 | 17.9 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
5.7 | 34.2 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
5.4 | 32.2 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
5.3 | 15.8 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
5.2 | 26.0 | GO:1902163 | negative regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902163) |
5.0 | 25.0 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
4.9 | 19.5 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
4.9 | 24.3 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
4.9 | 24.3 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
4.7 | 4.7 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
4.5 | 17.9 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
4.4 | 13.3 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
4.4 | 8.8 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
4.4 | 47.9 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
4.3 | 30.3 | GO:1904717 | regulation of AMPA glutamate receptor clustering(GO:1904717) |
4.3 | 21.6 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
4.1 | 12.4 | GO:0021682 | nerve maturation(GO:0021682) |
4.1 | 16.4 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
4.1 | 12.2 | GO:0021762 | substantia nigra development(GO:0021762) |
4.0 | 36.4 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
4.0 | 12.1 | GO:0060599 | lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
4.0 | 56.0 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
3.9 | 11.8 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
3.9 | 15.7 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
3.9 | 19.3 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
3.9 | 23.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
3.8 | 19.2 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
3.8 | 3.8 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
3.8 | 11.5 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
3.8 | 11.5 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
3.8 | 11.4 | GO:1904456 | negative regulation of neuronal action potential(GO:1904456) |
3.7 | 3.7 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
3.7 | 7.4 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
3.7 | 14.6 | GO:0021586 | pons maturation(GO:0021586) |
3.6 | 21.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
3.6 | 14.3 | GO:1904708 | granulosa cell apoptotic process(GO:1904700) regulation of granulosa cell apoptotic process(GO:1904708) |
3.6 | 10.7 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
3.6 | 21.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
3.5 | 3.5 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
3.4 | 13.6 | GO:0051182 | coenzyme transport(GO:0051182) |
3.4 | 3.4 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
3.4 | 3.4 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
3.4 | 27.0 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
3.3 | 3.3 | GO:1900673 | olefin metabolic process(GO:1900673) |
3.3 | 23.3 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
3.3 | 23.3 | GO:0051012 | microtubule sliding(GO:0051012) |
3.3 | 9.9 | GO:0060466 | activation of meiosis involved in egg activation(GO:0060466) |
3.3 | 26.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
3.3 | 9.8 | GO:0046959 | habituation(GO:0046959) |
3.3 | 45.7 | GO:0098970 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
3.2 | 25.8 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
3.2 | 9.7 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
3.2 | 9.6 | GO:0006169 | adenosine salvage(GO:0006169) dATP biosynthetic process(GO:0006175) |
3.2 | 9.6 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
3.1 | 18.7 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
3.1 | 3.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
3.0 | 6.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
3.0 | 9.1 | GO:0015881 | creatine transport(GO:0015881) |
3.0 | 9.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
3.0 | 8.9 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
3.0 | 8.9 | GO:0006867 | asparagine transport(GO:0006867) positive regulation of glutamine transport(GO:2000487) |
2.9 | 8.8 | GO:2000536 | negative regulation of entry of bacterium into host cell(GO:2000536) |
2.9 | 20.5 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
2.9 | 20.5 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
2.9 | 2.9 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
2.9 | 8.8 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
2.9 | 11.6 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
2.9 | 14.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
2.8 | 2.8 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
2.8 | 16.9 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
2.8 | 2.8 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
2.8 | 8.4 | GO:0048372 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) positive regulation of cardiac ventricle development(GO:1904414) |
2.8 | 8.3 | GO:0009629 | response to gravity(GO:0009629) |
2.8 | 11.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
2.7 | 27.4 | GO:0099639 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
2.7 | 10.8 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
2.7 | 8.1 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
2.7 | 8.0 | GO:0016131 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
2.7 | 13.4 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
2.7 | 40.0 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
2.7 | 32.0 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
2.7 | 8.0 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
2.6 | 7.9 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
2.6 | 5.2 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
2.6 | 10.4 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
2.6 | 10.4 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
2.6 | 5.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
2.6 | 7.8 | GO:0003167 | atrioventricular bundle cell differentiation(GO:0003167) |
2.6 | 10.3 | GO:0098886 | modification of dendritic spine(GO:0098886) |
2.5 | 10.2 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
2.5 | 22.8 | GO:0051775 | response to redox state(GO:0051775) |
2.5 | 22.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
2.5 | 17.5 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
2.5 | 12.5 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
2.5 | 9.9 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
2.5 | 7.4 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
2.5 | 39.7 | GO:0007413 | axonal fasciculation(GO:0007413) |
2.5 | 7.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
2.5 | 12.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
2.4 | 9.8 | GO:0097274 | urea homeostasis(GO:0097274) |
2.4 | 4.9 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
2.4 | 12.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
2.4 | 17.0 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
2.4 | 12.1 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
2.4 | 21.8 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
2.4 | 12.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
2.4 | 7.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
2.4 | 12.0 | GO:0097491 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
2.4 | 9.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
2.4 | 14.1 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
2.3 | 21.1 | GO:0032328 | alanine transport(GO:0032328) |
2.3 | 4.7 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
2.3 | 7.0 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
2.3 | 6.9 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
2.3 | 9.2 | GO:0098582 | innate vocalization behavior(GO:0098582) |
2.3 | 6.9 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
2.3 | 27.6 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
2.3 | 20.6 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
2.3 | 9.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
2.3 | 4.6 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
2.3 | 6.8 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
2.3 | 9.0 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
2.2 | 13.4 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
2.2 | 2.2 | GO:0070142 | synaptic vesicle budding(GO:0070142) |
2.2 | 4.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
2.2 | 6.7 | GO:0019413 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
2.2 | 17.7 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
2.2 | 2.2 | GO:0098964 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
2.2 | 4.4 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) |
2.2 | 15.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
2.2 | 2.2 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
2.2 | 6.6 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
2.2 | 6.5 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
2.2 | 4.4 | GO:0009644 | response to high light intensity(GO:0009644) |
2.2 | 10.8 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
2.2 | 17.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
2.1 | 12.9 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
2.1 | 30.0 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
2.1 | 6.4 | GO:0035934 | corticosterone secretion(GO:0035934) |
2.1 | 6.4 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
2.1 | 6.4 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
2.1 | 6.4 | GO:1990859 | cellular response to endothelin(GO:1990859) |
2.1 | 10.6 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
2.1 | 10.6 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
2.1 | 12.7 | GO:0042117 | monocyte activation(GO:0042117) |
2.1 | 2.1 | GO:0061290 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
2.1 | 4.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
2.1 | 2.1 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
2.1 | 25.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
2.1 | 6.3 | GO:0072720 | response to dithiothreitol(GO:0072720) |
2.1 | 10.4 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
2.1 | 4.2 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
2.1 | 4.1 | GO:0032899 | regulation of neurotrophin production(GO:0032899) |
2.1 | 2.1 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
2.1 | 10.3 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
2.1 | 2.1 | GO:0010046 | response to mycotoxin(GO:0010046) |
2.1 | 32.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
2.0 | 4.1 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
2.0 | 6.1 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
2.0 | 10.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
2.0 | 6.1 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
2.0 | 22.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
2.0 | 12.1 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
2.0 | 2.0 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
2.0 | 14.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
2.0 | 6.0 | GO:0006553 | lysine metabolic process(GO:0006553) |
2.0 | 2.0 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
2.0 | 6.0 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
2.0 | 9.9 | GO:1905035 | regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
2.0 | 11.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
2.0 | 3.9 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
2.0 | 5.9 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
2.0 | 5.9 | GO:0061107 | seminal vesicle development(GO:0061107) |
1.9 | 7.7 | GO:0038016 | insulin receptor internalization(GO:0038016) |
1.9 | 1.9 | GO:0001575 | globoside metabolic process(GO:0001575) |
1.9 | 3.8 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) |
1.9 | 11.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
1.9 | 5.7 | GO:0019417 | sulfur oxidation(GO:0019417) |
1.9 | 13.2 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.9 | 5.7 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
1.9 | 9.4 | GO:0051036 | regulation of endosome size(GO:0051036) |
1.9 | 1.9 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
1.9 | 5.7 | GO:1905161 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
1.9 | 5.6 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
1.9 | 22.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.9 | 3.7 | GO:0099541 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) |
1.9 | 11.1 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
1.9 | 3.7 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
1.8 | 1.8 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
1.8 | 7.4 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
1.8 | 5.5 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
1.8 | 1.8 | GO:0030043 | actin filament fragmentation(GO:0030043) |
1.8 | 5.5 | GO:0060596 | mammary placode formation(GO:0060596) |
1.8 | 3.6 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
1.8 | 16.3 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
1.8 | 9.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
1.8 | 1.8 | GO:1901080 | regulation of relaxation of smooth muscle(GO:1901080) positive regulation of relaxation of smooth muscle(GO:1901082) |
1.8 | 5.4 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
1.8 | 7.1 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
1.8 | 7.1 | GO:0003142 | cardiogenic plate morphogenesis(GO:0003142) regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification(GO:0060807) regulation of cardiac cell fate specification(GO:2000043) |
1.8 | 17.7 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
1.8 | 1.8 | GO:0033058 | directional locomotion(GO:0033058) |
1.8 | 3.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
1.8 | 7.0 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
1.8 | 10.6 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
1.8 | 17.5 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
1.7 | 7.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.7 | 17.5 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
1.7 | 5.2 | GO:0061438 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
1.7 | 6.9 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
1.7 | 6.9 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
1.7 | 5.2 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
1.7 | 15.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.7 | 1.7 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
1.7 | 6.9 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
1.7 | 6.9 | GO:0003360 | brainstem development(GO:0003360) |
1.7 | 6.8 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
1.7 | 5.1 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
1.7 | 27.3 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
1.7 | 1.7 | GO:0031104 | dendrite regeneration(GO:0031104) |
1.7 | 56.2 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
1.7 | 35.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.7 | 5.1 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
1.7 | 8.4 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
1.7 | 16.9 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
1.7 | 6.7 | GO:0030974 | thiamine pyrophosphate transport(GO:0030974) |
1.7 | 3.4 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
1.7 | 10.0 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
1.7 | 5.0 | GO:0098885 | modification of postsynaptic actin cytoskeleton(GO:0098885) |
1.7 | 13.2 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
1.7 | 19.8 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
1.6 | 29.7 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
1.6 | 8.1 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
1.6 | 11.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.6 | 32.4 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
1.6 | 4.9 | GO:0010232 | vascular transport(GO:0010232) milk ejection(GO:0060156) |
1.6 | 8.1 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
1.6 | 70.1 | GO:0030325 | adrenal gland development(GO:0030325) |
1.6 | 3.2 | GO:1905245 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
1.6 | 7.9 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
1.6 | 9.5 | GO:0034334 | adherens junction maintenance(GO:0034334) |
1.6 | 31.5 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
1.6 | 7.8 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.6 | 4.7 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
1.6 | 4.7 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
1.6 | 6.2 | GO:0046210 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
1.6 | 3.1 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
1.6 | 7.8 | GO:0099563 | modification of synaptic structure(GO:0099563) |
1.6 | 1.6 | GO:0046958 | nonassociative learning(GO:0046958) |
1.6 | 4.7 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
1.6 | 14.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
1.5 | 7.7 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
1.5 | 10.7 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
1.5 | 1.5 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
1.5 | 4.6 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
1.5 | 9.2 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
1.5 | 7.6 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
1.5 | 4.6 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
1.5 | 51.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
1.5 | 4.5 | GO:0061312 | BMP signaling pathway involved in heart development(GO:0061312) |
1.5 | 6.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.5 | 12.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
1.5 | 16.5 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
1.5 | 7.5 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
1.5 | 3.0 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
1.5 | 4.5 | GO:2001023 | regulation of response to drug(GO:2001023) |
1.5 | 3.0 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
1.5 | 8.9 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
1.5 | 16.3 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
1.5 | 4.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
1.5 | 4.4 | GO:0046491 | L-methylmalonyl-CoA metabolic process(GO:0046491) |
1.5 | 8.9 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
1.5 | 1.5 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
1.5 | 4.4 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
1.5 | 1.5 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
1.5 | 7.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
1.5 | 5.8 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
1.5 | 8.7 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
1.5 | 7.3 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
1.4 | 11.6 | GO:0070417 | cellular response to cold(GO:0070417) |
1.4 | 1.4 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
1.4 | 10.1 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
1.4 | 5.7 | GO:0048690 | regulation of sprouting of injured axon(GO:0048686) positive regulation of sprouting of injured axon(GO:0048687) regulation of axon extension involved in regeneration(GO:0048690) positive regulation of axon extension involved in regeneration(GO:0048691) |
1.4 | 28.6 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
1.4 | 21.4 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
1.4 | 2.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
1.4 | 4.3 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
1.4 | 5.6 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) |
1.4 | 5.6 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
1.4 | 5.6 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
1.4 | 5.6 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
1.4 | 18.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.4 | 4.2 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
1.4 | 1.4 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
1.4 | 1.4 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
1.4 | 9.7 | GO:0009405 | pathogenesis(GO:0009405) |
1.4 | 36.0 | GO:0071625 | vocalization behavior(GO:0071625) |
1.4 | 5.5 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
1.4 | 6.9 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
1.4 | 5.5 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
1.4 | 4.1 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.4 | 15.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
1.4 | 4.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
1.4 | 6.8 | GO:1902993 | positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
1.4 | 6.8 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.4 | 4.1 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
1.3 | 13.5 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.3 | 22.8 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
1.3 | 17.5 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
1.3 | 12.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.3 | 50.9 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
1.3 | 5.3 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.3 | 5.3 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
1.3 | 2.6 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
1.3 | 14.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
1.3 | 2.6 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.3 | 7.9 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.3 | 5.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.3 | 1.3 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
1.3 | 1.3 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
1.3 | 3.9 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
1.3 | 18.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
1.3 | 3.9 | GO:0033306 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
1.3 | 3.9 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
1.3 | 3.9 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
1.3 | 3.9 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
1.3 | 3.9 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
1.3 | 5.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.3 | 5.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.3 | 1.3 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
1.3 | 15.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
1.3 | 15.2 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) |
1.3 | 6.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.3 | 22.7 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
1.3 | 3.8 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
1.3 | 11.3 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
1.3 | 25.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
1.2 | 6.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
1.2 | 5.0 | GO:0080163 | regulation of protein serine/threonine phosphatase activity(GO:0080163) |
1.2 | 45.8 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
1.2 | 3.7 | GO:0021730 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
1.2 | 6.2 | GO:0015819 | lysine transport(GO:0015819) |
1.2 | 13.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
1.2 | 17.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
1.2 | 3.7 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.2 | 9.8 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
1.2 | 3.7 | GO:0031643 | positive regulation of myelination(GO:0031643) |
1.2 | 3.7 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
1.2 | 2.4 | GO:0018931 | naphthalene metabolic process(GO:0018931) naphthalene-containing compound metabolic process(GO:0090420) |
1.2 | 1.2 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
1.2 | 4.8 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
1.2 | 3.6 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
1.2 | 2.4 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.2 | 6.0 | GO:0070178 | D-serine metabolic process(GO:0070178) |
1.2 | 3.6 | GO:0019085 | early viral transcription(GO:0019085) |
1.2 | 2.4 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
1.2 | 39.6 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
1.2 | 2.4 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.2 | 2.4 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
1.2 | 13.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
1.2 | 1.2 | GO:0072244 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
1.2 | 1.2 | GO:0072014 | proximal tubule development(GO:0072014) |
1.2 | 9.6 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
1.2 | 6.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.2 | 4.8 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.2 | 2.4 | GO:0060492 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
1.2 | 19.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.2 | 2.4 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
1.2 | 3.5 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
1.2 | 3.5 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
1.2 | 11.7 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
1.2 | 22.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
1.2 | 7.0 | GO:0016264 | gap junction assembly(GO:0016264) |
1.2 | 2.3 | GO:0061043 | positive regulation of vascular wound healing(GO:0035470) regulation of vascular wound healing(GO:0061043) |
1.2 | 9.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
1.2 | 4.6 | GO:0055048 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
1.2 | 22.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
1.2 | 5.8 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
1.2 | 5.8 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
1.2 | 2.3 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.2 | 2.3 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
1.2 | 3.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
1.1 | 6.9 | GO:0036394 | amylase secretion(GO:0036394) |
1.1 | 3.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.1 | 27.5 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
1.1 | 4.6 | GO:0003383 | apical constriction(GO:0003383) |
1.1 | 8.0 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
1.1 | 32.9 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
1.1 | 6.8 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
1.1 | 1.1 | GO:0044830 | modulation by host of viral RNA genome replication(GO:0044830) |
1.1 | 2.3 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
1.1 | 30.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.1 | 4.5 | GO:0060667 | fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
1.1 | 3.4 | GO:0044849 | estrous cycle(GO:0044849) |
1.1 | 3.4 | GO:0014002 | astrocyte development(GO:0014002) |
1.1 | 3.3 | GO:0032976 | release of matrix enzymes from mitochondria(GO:0032976) B cell receptor apoptotic signaling pathway(GO:1990117) |
1.1 | 6.6 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
1.1 | 19.9 | GO:0007220 | Notch receptor processing(GO:0007220) |
1.1 | 3.3 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
1.1 | 29.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.1 | 9.9 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
1.1 | 2.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
1.1 | 7.7 | GO:0051958 | methotrexate transport(GO:0051958) |
1.1 | 4.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
1.1 | 20.8 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
1.1 | 1.1 | GO:1901003 | negative regulation of fermentation(GO:1901003) |
1.1 | 4.4 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
1.1 | 6.5 | GO:0035902 | response to immobilization stress(GO:0035902) |
1.1 | 7.6 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
1.1 | 2.2 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
1.1 | 3.3 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
1.1 | 5.4 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
1.1 | 24.9 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
1.1 | 10.8 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
1.1 | 4.3 | GO:1904453 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
1.1 | 9.7 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.1 | 3.2 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
1.1 | 77.6 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
1.1 | 1.1 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
1.1 | 19.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
1.1 | 6.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.1 | 2.1 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
1.1 | 15.0 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
1.1 | 6.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.1 | 7.5 | GO:0015871 | choline transport(GO:0015871) |
1.1 | 4.3 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
1.1 | 7.4 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
1.1 | 8.5 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
1.0 | 3.1 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
1.0 | 4.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.0 | 47.9 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
1.0 | 4.1 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
1.0 | 8.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.0 | 4.1 | GO:2001107 | negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
1.0 | 1.0 | GO:0031620 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
1.0 | 5.2 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
1.0 | 9.3 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
1.0 | 4.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.0 | 7.2 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
1.0 | 2.0 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
1.0 | 6.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
1.0 | 1.0 | GO:0051795 | positive regulation of catagen(GO:0051795) |
1.0 | 7.0 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
1.0 | 1.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
1.0 | 3.0 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
1.0 | 10.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
1.0 | 10.0 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
1.0 | 7.0 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
1.0 | 7.0 | GO:0060309 | elastin catabolic process(GO:0060309) |
1.0 | 34.8 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
1.0 | 8.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
1.0 | 2.0 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
1.0 | 4.0 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
1.0 | 3.0 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
1.0 | 3.0 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
1.0 | 15.7 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
1.0 | 2.9 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
1.0 | 4.9 | GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
1.0 | 1.0 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.0 | 6.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
1.0 | 1.0 | GO:0008038 | neuron recognition(GO:0008038) |
1.0 | 25.4 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
1.0 | 1.0 | GO:0044851 | hair cycle phase(GO:0044851) |
1.0 | 10.7 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
1.0 | 1.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.0 | 2.9 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.0 | 7.8 | GO:0035493 | SNARE complex assembly(GO:0035493) |
1.0 | 4.9 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
1.0 | 1.9 | GO:0003032 | detection of oxygen(GO:0003032) |
1.0 | 3.9 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
1.0 | 2.9 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
1.0 | 37.5 | GO:0035329 | hippo signaling(GO:0035329) |
1.0 | 86.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.0 | 6.7 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
1.0 | 8.6 | GO:0006108 | malate metabolic process(GO:0006108) |
1.0 | 1.9 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
0.9 | 6.6 | GO:0097324 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
0.9 | 2.8 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.9 | 4.7 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.9 | 4.7 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.9 | 2.8 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
0.9 | 1.9 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.9 | 5.6 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.9 | 5.6 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.9 | 4.7 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.9 | 0.9 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.9 | 1.9 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.9 | 5.5 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.9 | 8.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) paranodal junction assembly(GO:0030913) |
0.9 | 0.9 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.9 | 3.7 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.9 | 3.7 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.9 | 2.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.9 | 2.7 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.9 | 12.7 | GO:0032098 | regulation of appetite(GO:0032098) |
0.9 | 10.0 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.9 | 3.6 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.9 | 60.0 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.9 | 1.8 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.9 | 4.5 | GO:0035989 | tendon development(GO:0035989) |
0.9 | 13.6 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.9 | 9.1 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.9 | 12.7 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) |
0.9 | 5.4 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.9 | 2.7 | GO:0034031 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) acetyl-CoA catabolic process(GO:0046356) |
0.9 | 2.7 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.9 | 2.7 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.9 | 2.7 | GO:0098749 | cerebellar neuron development(GO:0098749) |
0.9 | 4.5 | GO:0015888 | thiamine transport(GO:0015888) |
0.9 | 3.6 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.9 | 4.5 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.9 | 8.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.9 | 8.0 | GO:0015671 | oxygen transport(GO:0015671) |
0.9 | 8.0 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.9 | 2.7 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.9 | 2.7 | GO:0051030 | snRNA transport(GO:0051030) |
0.9 | 1.8 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.9 | 0.9 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.9 | 11.4 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.9 | 7.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.9 | 7.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.9 | 6.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.9 | 3.5 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.9 | 5.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.9 | 2.6 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.9 | 2.6 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.9 | 12.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.9 | 6.9 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.9 | 18.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.9 | 3.5 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
0.9 | 3.5 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.9 | 6.9 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.9 | 6.0 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.9 | 11.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.9 | 2.6 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.9 | 1.7 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.9 | 3.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.9 | 1.7 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.9 | 0.9 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
0.8 | 0.8 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.8 | 23.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.8 | 9.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.8 | 2.5 | GO:0060618 | nipple development(GO:0060618) |
0.8 | 0.8 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.8 | 1.7 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
0.8 | 1.7 | GO:0030803 | negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) negative regulation of cAMP biosynthetic process(GO:0030818) |
0.8 | 4.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.8 | 16.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.8 | 10.0 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.8 | 0.8 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.8 | 7.5 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.8 | 2.5 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.8 | 3.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.8 | 14.9 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.8 | 2.5 | GO:0048627 | myoblast development(GO:0048627) |
0.8 | 2.5 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.8 | 4.1 | GO:0060356 | leucine import(GO:0060356) |
0.8 | 5.0 | GO:0035106 | operant conditioning(GO:0035106) |
0.8 | 9.9 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.8 | 2.5 | GO:2000984 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
0.8 | 9.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.8 | 0.8 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.8 | 21.2 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.8 | 8.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.8 | 5.7 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.8 | 12.1 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.8 | 7.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.8 | 2.4 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
0.8 | 6.4 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.8 | 3.2 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
0.8 | 4.8 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.8 | 4.0 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
0.8 | 16.0 | GO:0002076 | osteoblast development(GO:0002076) |
0.8 | 3.2 | GO:0042245 | RNA repair(GO:0042245) |
0.8 | 0.8 | GO:0001941 | postsynaptic membrane organization(GO:0001941) |
0.8 | 13.4 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.8 | 18.8 | GO:0034389 | lipid particle organization(GO:0034389) |
0.8 | 9.4 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.8 | 2.3 | GO:0090367 | negative regulation of mRNA modification(GO:0090367) |
0.8 | 3.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.8 | 2.3 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.8 | 7.8 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.8 | 1.6 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.8 | 7.0 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) |
0.8 | 0.8 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.8 | 5.4 | GO:0051645 | Golgi localization(GO:0051645) |
0.8 | 3.1 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.8 | 2.3 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.8 | 6.9 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.8 | 11.5 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.8 | 6.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.8 | 6.9 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.8 | 25.9 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.8 | 0.8 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
0.8 | 2.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.8 | 12.1 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.8 | 2.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.8 | 6.0 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.8 | 3.0 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
0.7 | 1.5 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.7 | 9.0 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.7 | 3.7 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) |
0.7 | 6.0 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.7 | 3.7 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.7 | 9.7 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.7 | 7.4 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.7 | 6.7 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.7 | 4.5 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.7 | 1.5 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.7 | 33.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.7 | 6.6 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.7 | 2.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.7 | 2.9 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.7 | 0.7 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
0.7 | 5.9 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.7 | 0.7 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.7 | 7.3 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.7 | 2.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.7 | 5.8 | GO:0031179 | peptide modification(GO:0031179) |
0.7 | 2.9 | GO:0046271 | coumarin catabolic process(GO:0046226) phenylpropanoid catabolic process(GO:0046271) |
0.7 | 1.4 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.7 | 5.7 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.7 | 13.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.7 | 4.3 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.7 | 2.9 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
0.7 | 2.9 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.7 | 2.1 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
0.7 | 5.7 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.7 | 17.8 | GO:0043113 | receptor clustering(GO:0043113) |
0.7 | 1.4 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.7 | 4.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.7 | 36.1 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.7 | 2.8 | GO:0097298 | regulation of nucleus size(GO:0097298) |
0.7 | 4.9 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.7 | 1.4 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.7 | 0.7 | GO:0097688 | glutamate receptor clustering(GO:0097688) |
0.7 | 5.6 | GO:0015675 | nickel cation transport(GO:0015675) |
0.7 | 2.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.7 | 2.1 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.7 | 4.9 | GO:0015705 | iodide transport(GO:0015705) |
0.7 | 0.7 | GO:0021764 | amygdala development(GO:0021764) |
0.7 | 8.3 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
0.7 | 0.7 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.7 | 5.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.7 | 10.4 | GO:0099612 | protein localization to axon(GO:0099612) |
0.7 | 2.8 | GO:0006983 | ER overload response(GO:0006983) |
0.7 | 2.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.7 | 22.7 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.7 | 3.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.7 | 4.8 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.7 | 2.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.7 | 2.7 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.7 | 3.4 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.7 | 9.5 | GO:0006828 | manganese ion transport(GO:0006828) |
0.7 | 17.6 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.7 | 3.4 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.7 | 7.4 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
0.7 | 4.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.7 | 9.4 | GO:0014047 | glutamate secretion(GO:0014047) |
0.7 | 4.0 | GO:0001757 | somite specification(GO:0001757) |
0.7 | 0.7 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.7 | 0.7 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.7 | 4.0 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.7 | 2.0 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.7 | 2.6 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.7 | 5.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.7 | 4.0 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.7 | 4.6 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.7 | 0.7 | GO:1903969 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.7 | 14.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.7 | 1.3 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.7 | 3.9 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.6 | 68.8 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.6 | 1.9 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.6 | 4.5 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.6 | 2.6 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.6 | 2.6 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.6 | 1.3 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.6 | 2.6 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.6 | 0.6 | GO:2000328 | regulation of T-helper 17 cell lineage commitment(GO:2000328) |
0.6 | 23.7 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.6 | 8.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.6 | 3.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.6 | 1.9 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.6 | 7.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.6 | 2.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.6 | 10.1 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.6 | 3.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.6 | 6.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.6 | 1.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.6 | 0.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.6 | 6.2 | GO:0036065 | fucosylation(GO:0036065) |
0.6 | 1.9 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.6 | 14.9 | GO:0033622 | integrin activation(GO:0033622) |
0.6 | 2.5 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.6 | 1.9 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.6 | 0.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.6 | 1.9 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.6 | 9.2 | GO:0014850 | response to muscle activity(GO:0014850) |
0.6 | 1.2 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.6 | 2.4 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.6 | 0.6 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.6 | 10.9 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.6 | 4.9 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.6 | 1.8 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.6 | 1.2 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.6 | 8.5 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.6 | 5.4 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.6 | 3.6 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.6 | 1.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.6 | 5.4 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.6 | 3.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.6 | 1.2 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.6 | 12.0 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.6 | 4.2 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.6 | 0.6 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.6 | 1.8 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.6 | 1.8 | GO:0042196 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
0.6 | 9.5 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.6 | 8.9 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.6 | 30.2 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.6 | 3.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.6 | 1.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.6 | 8.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.6 | 0.6 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.6 | 1.2 | GO:0016240 | autophagosome docking(GO:0016240) |
0.6 | 0.6 | GO:2000830 | vacuolar phosphate transport(GO:0007037) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.6 | 5.9 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.6 | 9.9 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.6 | 3.5 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.6 | 8.8 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.6 | 3.5 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.6 | 5.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.6 | 3.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.6 | 1.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.6 | 1.7 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.6 | 2.3 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) |
0.6 | 10.3 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.6 | 1.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.6 | 4.0 | GO:0071569 | protein ufmylation(GO:0071569) |
0.6 | 1.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.6 | 1.7 | GO:0070104 | negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) |
0.6 | 3.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.6 | 2.3 | GO:0070384 | Harderian gland development(GO:0070384) |
0.6 | 2.3 | GO:0003017 | lymph circulation(GO:0003017) |
0.6 | 1.7 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
0.6 | 0.6 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.6 | 13.4 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.6 | 3.9 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.6 | 1.1 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.6 | 2.2 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.6 | 3.3 | GO:0090656 | t-circle formation(GO:0090656) |
0.6 | 2.8 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.6 | 2.8 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.6 | 1.1 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.5 | 2.7 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.5 | 4.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.5 | 4.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.5 | 4.3 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.5 | 5.4 | GO:0035878 | nail development(GO:0035878) |
0.5 | 1.1 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.5 | 0.5 | GO:0006903 | vesicle targeting(GO:0006903) |
0.5 | 3.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.5 | 2.7 | GO:0030432 | peristalsis(GO:0030432) |
0.5 | 1.1 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.5 | 1.6 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
0.5 | 3.7 | GO:0030969 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
0.5 | 8.5 | GO:0042407 | cristae formation(GO:0042407) |
0.5 | 0.5 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.5 | 0.5 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.5 | 2.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.5 | 2.1 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.5 | 8.9 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.5 | 2.1 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.5 | 2.6 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.5 | 0.5 | GO:1904959 | regulation of cytochrome-c oxidase activity(GO:1904959) |
0.5 | 3.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.5 | 4.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.5 | 1.0 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.5 | 1.5 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.5 | 6.7 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.5 | 1.0 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.5 | 1.0 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.5 | 3.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.5 | 4.1 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.5 | 7.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.5 | 0.5 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 2.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.5 | 6.5 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.5 | 0.5 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.5 | 1.0 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.5 | 4.5 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.5 | 2.5 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.5 | 4.0 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.5 | 2.0 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
0.5 | 2.0 | GO:0000105 | histidine biosynthetic process(GO:0000105) |
0.5 | 1.5 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.5 | 1.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.5 | 4.9 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.5 | 1.0 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
0.5 | 1.0 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.5 | 2.0 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.5 | 0.5 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.5 | 6.3 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.5 | 1.5 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.5 | 3.9 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.5 | 2.4 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.5 | 1.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.5 | 1.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.5 | 3.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 2.4 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.5 | 1.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.5 | 9.5 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.5 | 4.3 | GO:0001553 | luteinization(GO:0001553) |
0.5 | 3.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.5 | 1.4 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.5 | 10.0 | GO:0044243 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.5 | 14.2 | GO:0019835 | cytolysis(GO:0019835) |
0.5 | 1.4 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.5 | 2.4 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.5 | 4.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.5 | 35.8 | GO:0006821 | chloride transport(GO:0006821) |
0.5 | 1.9 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.5 | 7.9 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.5 | 5.1 | GO:0030242 | pexophagy(GO:0030242) |
0.5 | 2.3 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.5 | 2.3 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.5 | 12.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.5 | 2.3 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.5 | 2.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.5 | 0.5 | GO:0015679 | plasma membrane copper ion transport(GO:0015679) copper ion import across plasma membrane(GO:0098705) copper ion import into cell(GO:1902861) |
0.5 | 2.7 | GO:0002188 | translation reinitiation(GO:0002188) |
0.5 | 17.4 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.5 | 0.9 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
0.5 | 9.6 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.5 | 0.5 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.5 | 15.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 1.4 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.5 | 2.7 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.5 | 3.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.5 | 2.7 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.5 | 1.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.4 | 1.3 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.4 | 1.3 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.4 | 9.8 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.4 | 2.7 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.4 | 3.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.4 | 1.3 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.4 | 1.3 | GO:0034201 | response to oleic acid(GO:0034201) |
0.4 | 1.3 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.4 | 8.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.4 | 6.6 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.4 | 0.9 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.4 | 0.4 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.4 | 1.8 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.4 | 11.8 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.4 | 4.4 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.4 | 17.9 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.4 | 7.8 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.4 | 3.0 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.4 | 7.8 | GO:0000338 | protein deneddylation(GO:0000338) |
0.4 | 0.4 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.4 | 0.4 | GO:0010159 | specification of organ position(GO:0010159) |
0.4 | 1.3 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.4 | 3.8 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.4 | 0.9 | GO:0071436 | sodium ion export(GO:0071436) |
0.4 | 4.3 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.4 | 3.0 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.4 | 5.5 | GO:0007588 | excretion(GO:0007588) |
0.4 | 1.3 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.4 | 0.4 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.4 | 0.4 | GO:1903699 | tarsal gland development(GO:1903699) |
0.4 | 1.3 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.4 | 0.4 | GO:0040038 | meiotic cytokinesis(GO:0033206) polar body extrusion after meiotic divisions(GO:0040038) |
0.4 | 5.0 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.4 | 1.7 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.4 | 0.4 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.4 | 1.7 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
0.4 | 1.7 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.4 | 5.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.4 | 0.4 | GO:0061643 | regulation of negative chemotaxis(GO:0050923) chemorepulsion of axon(GO:0061643) |
0.4 | 1.7 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.4 | 17.0 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.4 | 2.5 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.4 | 2.5 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
0.4 | 3.7 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.4 | 3.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 1.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.4 | 1.6 | GO:0010286 | heat acclimation(GO:0010286) |
0.4 | 1.2 | GO:0034214 | protein hexamerization(GO:0034214) |
0.4 | 2.8 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.4 | 15.7 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.4 | 3.6 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.4 | 2.0 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.4 | 1.6 | GO:0071449 | response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
0.4 | 3.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.4 | 12.5 | GO:0015698 | inorganic anion transport(GO:0015698) |
0.4 | 12.0 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.4 | 0.8 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.4 | 9.2 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.4 | 0.4 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.4 | 2.0 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.4 | 1.6 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.4 | 26.8 | GO:0050804 | modulation of synaptic transmission(GO:0050804) |
0.4 | 1.2 | GO:0015867 | ATP transport(GO:0015867) |
0.4 | 1.2 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.4 | 1.6 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.4 | 1.2 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.4 | 0.8 | GO:0043379 | memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) |
0.4 | 4.7 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.4 | 0.4 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.4 | 0.4 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.4 | 0.8 | GO:0032570 | response to progesterone(GO:0032570) |
0.4 | 56.6 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.4 | 2.7 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.4 | 3.1 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.4 | 1.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.4 | 0.8 | GO:0046882 | regulation of follicle-stimulating hormone secretion(GO:0046880) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.4 | 0.4 | GO:0072174 | kidney rudiment formation(GO:0072003) metanephric tubule formation(GO:0072174) |
0.4 | 1.9 | GO:0015886 | heme transport(GO:0015886) |
0.4 | 1.1 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.4 | 3.0 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.4 | 1.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.4 | 1.9 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.4 | 0.4 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) |
0.4 | 2.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.4 | 0.7 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.4 | 4.8 | GO:0045187 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.4 | 1.8 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.4 | 1.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.4 | 1.5 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.4 | 1.8 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.4 | 4.8 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.4 | 6.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.4 | 1.1 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.4 | 7.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.4 | 0.4 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.4 | 2.2 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.4 | 2.5 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.4 | 6.8 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.4 | 1.1 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
0.4 | 7.2 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.4 | 2.9 | GO:0097461 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.4 | 0.7 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.4 | 1.4 | GO:0098909 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.4 | 3.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.4 | 4.6 | GO:0007000 | nucleolus organization(GO:0007000) |
0.4 | 0.4 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.4 | 3.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.3 | 0.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.3 | 1.4 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.3 | 2.4 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.3 | 1.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.3 | 1.4 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.3 | 2.1 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.3 | 4.8 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.3 | 3.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 5.4 | GO:0008542 | visual learning(GO:0008542) |
0.3 | 1.3 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.3 | 2.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 14.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.3 | 0.7 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.3 | 5.0 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.3 | 1.0 | GO:0048840 | otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
0.3 | 5.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.3 | 1.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 1.3 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.3 | 1.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 0.7 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
0.3 | 2.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 1.3 | GO:0015846 | polyamine transport(GO:0015846) |
0.3 | 0.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 1.0 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.3 | 0.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.3 | 0.6 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.3 | 2.2 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.3 | 0.6 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.3 | 0.9 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.3 | 0.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 2.2 | GO:0043482 | pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) |
0.3 | 1.2 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.3 | 0.6 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.3 | 5.2 | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) |
0.3 | 0.9 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.3 | 2.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.3 | 0.9 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.3 | 1.5 | GO:0042640 | anagen(GO:0042640) |
0.3 | 0.3 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.3 | 2.7 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.3 | 1.2 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.3 | 1.2 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.3 | 1.5 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.3 | 0.6 | GO:0015817 | histidine transport(GO:0015817) |
0.3 | 4.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.3 | 0.9 | GO:0097475 | motor neuron migration(GO:0097475) |
0.3 | 3.2 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.3 | 0.6 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 1.4 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.3 | 21.7 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.3 | 1.1 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
0.3 | 1.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 0.6 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.3 | 1.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.3 | 0.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 1.4 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.3 | 0.6 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.3 | 3.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.3 | 0.6 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.3 | 2.5 | GO:0040023 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.3 | 9.5 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
0.3 | 0.3 | GO:0051181 | cofactor transport(GO:0051181) |
0.3 | 1.4 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.3 | 0.3 | GO:0042048 | olfactory behavior(GO:0042048) |
0.3 | 0.3 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.3 | 2.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 1.9 | GO:0045056 | transcytosis(GO:0045056) |
0.3 | 1.4 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
0.3 | 1.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 0.5 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.3 | 0.8 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.3 | 0.8 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.3 | 1.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.3 | 0.5 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.3 | 3.5 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.3 | 5.5 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.3 | 4.2 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.3 | 0.8 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.3 | 1.5 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.3 | 1.8 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.3 | 2.3 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.3 | 6.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.3 | 4.0 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.3 | 2.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.3 | 2.3 | GO:0006573 | valine metabolic process(GO:0006573) |
0.2 | 5.2 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.2 | 1.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 1.0 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.2 | 0.2 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.2 | 1.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.2 | 1.2 | GO:0022406 | membrane docking(GO:0022406) |
0.2 | 0.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 2.4 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.2 | 0.7 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.2 | 0.5 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.2 | 0.7 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.2 | 2.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 1.2 | GO:0046073 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
0.2 | 4.7 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.2 | 5.6 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.2 | 0.5 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.7 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 4.6 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.2 | 0.9 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.2 | 1.6 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.2 | 2.7 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.2 | 0.7 | GO:0006530 | asparagine catabolic process(GO:0006530) |
0.2 | 1.8 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 1.1 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
0.2 | 0.7 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.7 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 1.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 0.9 | GO:0018158 | protein oxidation(GO:0018158) |
0.2 | 2.0 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.2 | 1.5 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.2 | 0.9 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.2 | 13.5 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.2 | 1.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.2 | 1.7 | GO:0097205 | renal filtration(GO:0097205) |
0.2 | 1.5 | GO:0009650 | UV protection(GO:0009650) |
0.2 | 0.9 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.2 | 0.4 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.2 | 6.0 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 1.9 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.2 | 1.1 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.2 | 0.8 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 0.6 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
0.2 | 1.1 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
0.2 | 0.6 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.2 | 2.5 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.2 | 2.5 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 0.6 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.2 | 6.8 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.2 | 1.2 | GO:0046102 | inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
0.2 | 1.2 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.2 | 6.7 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
0.2 | 0.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.2 | 2.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.8 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 1.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 1.8 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.2 | 0.2 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.2 | 3.6 | GO:0007041 | lysosomal transport(GO:0007041) |
0.2 | 1.4 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 2.5 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.2 | 1.2 | GO:0035640 | exploration behavior(GO:0035640) |
0.2 | 0.6 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.2 | 0.6 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.2 | 1.2 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.2 | 0.8 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.2 | 1.7 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 0.4 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 1.5 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.2 | 1.3 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 0.8 | GO:0060157 | urinary bladder development(GO:0060157) |
0.2 | 0.2 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.2 | 1.5 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.2 | 1.7 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 3.7 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.2 | 0.4 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.2 | 1.5 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.2 | 0.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.2 | 2.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 4.2 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.2 | 1.3 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.2 | 0.7 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 0.4 | GO:1904851 | positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.2 | 1.6 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.2 | 0.2 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 0.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.2 | 0.4 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.2 | 1.4 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 0.5 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 1.6 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.2 | 2.9 | GO:0007612 | learning(GO:0007612) |
0.2 | 2.2 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
0.2 | 0.7 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 1.2 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.2 | 12.6 | GO:0061025 | membrane fusion(GO:0061025) |
0.2 | 1.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 0.7 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.2 | 0.2 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
0.2 | 0.5 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 0.3 | GO:0021554 | optic nerve development(GO:0021554) |
0.2 | 1.9 | GO:0032731 | positive regulation of interleukin-1 beta production(GO:0032731) |
0.2 | 6.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 0.5 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.2 | 1.4 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.2 | 1.7 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.2 | 2.3 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.2 | 7.7 | GO:0050905 | neuromuscular process(GO:0050905) |
0.2 | 2.0 | GO:0034766 | negative regulation of ion transmembrane transport(GO:0034766) |
0.2 | 0.8 | GO:0019076 | viral release from host cell(GO:0019076) |
0.2 | 0.6 | GO:0015904 | tetracycline transport(GO:0015904) |
0.2 | 0.5 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.2 | 0.2 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 0.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.3 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.1 | 1.0 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.4 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.6 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.1 | 0.6 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 6.9 | GO:0044042 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.1 | 6.3 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.1 | 1.2 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.1 | 0.7 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.1 | 0.6 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 0.6 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.1 | 0.6 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 1.5 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 2.0 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 4.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 1.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 1.5 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 0.9 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.1 | GO:0002664 | positive regulation of tolerance induction(GO:0002645) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) |
0.1 | 1.8 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 0.9 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.3 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 1.0 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 1.6 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.1 | 1.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.7 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 2.2 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 2.1 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.1 | 1.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.5 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 0.2 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.4 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.4 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.6 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.1 | 1.4 | GO:0034311 | diol metabolic process(GO:0034311) |
0.1 | 0.6 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.1 | 0.3 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) negative regulation by virus of viral protein levels in host cell(GO:0046725) |
0.1 | 0.7 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 7.4 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.1 | 0.9 | GO:0003016 | respiratory system process(GO:0003016) |
0.1 | 0.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 3.5 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.1 | 1.9 | GO:0015992 | proton transport(GO:0015992) |
0.1 | 0.7 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 0.4 | GO:0042335 | cuticle development(GO:0042335) |
0.1 | 0.9 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.1 | 0.9 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 3.5 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 1.0 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.2 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.7 | GO:0085029 | elastic fiber assembly(GO:0048251) extracellular matrix assembly(GO:0085029) |
0.1 | 0.3 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.1 | 0.5 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 2.1 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 2.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 4.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.2 | GO:0070194 | synaptonemal complex disassembly(GO:0070194) |
0.1 | 1.8 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.2 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 1.6 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.3 | GO:0060967 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
0.1 | 1.0 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.5 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 4.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.1 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.1 | 0.1 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.1 | 1.1 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.3 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.3 | GO:0036035 | osteoclast development(GO:0036035) |
0.1 | 0.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.6 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.1 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 1.8 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.9 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.1 | 0.1 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.1 | 0.6 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.3 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.3 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.1 | 1.3 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.1 | 0.2 | GO:0046072 | dTDP biosynthetic process(GO:0006233) dTDP metabolic process(GO:0046072) |
0.1 | 0.6 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 0.4 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 0.2 | GO:0018364 | box C/D snoRNA 3'-end processing(GO:0000494) peptidyl-glutamine methylation(GO:0018364) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.1 | 0.3 | GO:1901160 | primary amino compound metabolic process(GO:1901160) |
0.1 | 0.7 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.1 | 0.3 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.1 | 0.2 | GO:0045123 | cellular extravasation(GO:0045123) |
0.1 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.2 | GO:0006560 | proline metabolic process(GO:0006560) |
0.1 | 0.1 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 0.4 | GO:0097435 | fibril organization(GO:0097435) |
0.1 | 2.1 | GO:0050808 | synapse organization(GO:0050808) |
0.1 | 0.9 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 7.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 2.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 1.5 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.4 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 0.3 | GO:2000345 | regulation of hepatocyte proliferation(GO:2000345) |
0.0 | 0.3 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.0 | 0.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.0 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.0 | 0.2 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.0 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.6 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.0 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.0 | 0.3 | GO:0072010 | glomerular epithelium development(GO:0072010) |
0.0 | 0.1 | GO:0051455 | attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation(GO:0051455) microtubule cytoskeleton organization involved in homologous chromosome segregation(GO:0090172) |
0.0 | 0.1 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.0 | 0.1 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.0 | 0.3 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.1 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.0 | 0.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.1 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.0 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.2 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.2 | GO:0030801 | positive regulation of cyclic nucleotide metabolic process(GO:0030801) |
0.0 | 0.3 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 0.0 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.1 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.1 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.0 | 0.1 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.0 | 35.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
5.4 | 16.1 | GO:0098830 | presynaptic endosome(GO:0098830) |
5.1 | 56.5 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
4.7 | 23.5 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
4.6 | 23.1 | GO:0044308 | axonal spine(GO:0044308) |
4.5 | 18.2 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
4.3 | 17.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
4.0 | 16.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
4.0 | 59.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
3.8 | 64.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
3.7 | 18.5 | GO:0044301 | climbing fiber(GO:0044301) |
3.6 | 3.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
3.6 | 10.8 | GO:0048179 | activin receptor complex(GO:0048179) |
3.6 | 14.2 | GO:0014802 | terminal cisterna(GO:0014802) |
3.5 | 3.5 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
3.4 | 17.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
3.3 | 48.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
3.2 | 3.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
3.1 | 12.5 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
3.0 | 45.5 | GO:0031209 | SCAR complex(GO:0031209) |
2.9 | 37.3 | GO:0098845 | postsynaptic endosome(GO:0098845) |
2.8 | 65.5 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
2.8 | 138.5 | GO:0032590 | dendrite membrane(GO:0032590) |
2.7 | 21.4 | GO:0033269 | internode region of axon(GO:0033269) |
2.6 | 39.1 | GO:0043083 | synaptic cleft(GO:0043083) |
2.5 | 93.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
2.4 | 14.6 | GO:0044305 | calyx of Held(GO:0044305) |
2.4 | 7.2 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
2.4 | 14.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
2.3 | 2.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
2.2 | 4.4 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
2.2 | 2.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
2.2 | 6.6 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
2.2 | 6.6 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
2.2 | 21.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
2.1 | 31.9 | GO:0045180 | basal cortex(GO:0045180) |
2.1 | 10.5 | GO:0035976 | AP1 complex(GO:0035976) |
2.1 | 28.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
2.0 | 10.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
2.0 | 2.0 | GO:0030478 | actin cap(GO:0030478) |
2.0 | 37.9 | GO:0097470 | ribbon synapse(GO:0097470) |
2.0 | 10.0 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) extrinsic component of postsynaptic membrane(GO:0098890) |
2.0 | 25.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
2.0 | 15.8 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
2.0 | 3.9 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
2.0 | 5.9 | GO:0030904 | retromer complex(GO:0030904) |
2.0 | 23.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.9 | 3.9 | GO:1990909 | Wnt signalosome(GO:1990909) |
1.9 | 45.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.9 | 3.7 | GO:0060187 | cell pole(GO:0060187) |
1.9 | 75.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.8 | 9.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.8 | 16.3 | GO:0045298 | tubulin complex(GO:0045298) |
1.8 | 10.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.8 | 5.3 | GO:0034774 | secretory granule lumen(GO:0034774) cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
1.8 | 22.9 | GO:0097427 | microtubule bundle(GO:0097427) |
1.8 | 12.3 | GO:0097444 | spine apparatus(GO:0097444) |
1.7 | 10.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.7 | 27.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.7 | 1.7 | GO:0019034 | viral replication complex(GO:0019034) |
1.7 | 13.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
1.6 | 62.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.6 | 3.3 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
1.6 | 9.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.6 | 11.3 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
1.6 | 8.0 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.5 | 6.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
1.5 | 1.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.5 | 7.5 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
1.5 | 10.5 | GO:1990246 | uniplex complex(GO:1990246) |
1.5 | 1.5 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
1.5 | 4.4 | GO:0031904 | endosome lumen(GO:0031904) |
1.5 | 1.5 | GO:0043291 | RAVE complex(GO:0043291) |
1.5 | 2.9 | GO:0044753 | amphisome(GO:0044753) |
1.5 | 14.6 | GO:0016011 | dystroglycan complex(GO:0016011) |
1.5 | 24.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.4 | 17.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.4 | 5.7 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
1.4 | 12.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.4 | 119.7 | GO:0043198 | dendritic shaft(GO:0043198) |
1.4 | 4.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.4 | 6.9 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
1.4 | 1.4 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
1.4 | 2.8 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
1.4 | 1.4 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
1.4 | 8.2 | GO:0097443 | sorting endosome(GO:0097443) |
1.4 | 1.4 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
1.3 | 2.7 | GO:0016939 | kinesin II complex(GO:0016939) |
1.3 | 8.0 | GO:0008091 | spectrin(GO:0008091) |
1.3 | 62.2 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
1.3 | 5.2 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
1.3 | 5.2 | GO:0072534 | perineuronal net(GO:0072534) |
1.3 | 13.0 | GO:0005883 | neurofilament(GO:0005883) |
1.3 | 15.6 | GO:0070852 | cell body fiber(GO:0070852) |
1.3 | 2.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.3 | 121.1 | GO:0043195 | terminal bouton(GO:0043195) |
1.3 | 15.4 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.3 | 6.4 | GO:0005955 | calcineurin complex(GO:0005955) |
1.3 | 40.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
1.3 | 2.5 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.2 | 3.7 | GO:0032437 | cuticular plate(GO:0032437) |
1.2 | 48.7 | GO:0043194 | axon initial segment(GO:0043194) |
1.2 | 4.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.2 | 3.6 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
1.2 | 32.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
1.2 | 3.5 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
1.2 | 7.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
1.2 | 1.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
1.2 | 5.8 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.2 | 6.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.1 | 3.4 | GO:0070985 | TFIIK complex(GO:0070985) |
1.1 | 2.3 | GO:0033270 | paranode region of axon(GO:0033270) |
1.1 | 69.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.1 | 3.3 | GO:0097144 | BAX complex(GO:0097144) |
1.1 | 403.6 | GO:0097060 | synaptic membrane(GO:0097060) |
1.1 | 3.3 | GO:0097632 | extrinsic component of pre-autophagosomal structure membrane(GO:0097632) |
1.1 | 13.9 | GO:0016342 | catenin complex(GO:0016342) |
1.1 | 3.2 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
1.0 | 4.1 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
1.0 | 16.2 | GO:0097449 | astrocyte projection(GO:0097449) |
1.0 | 6.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
1.0 | 59.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
1.0 | 147.6 | GO:0008021 | synaptic vesicle(GO:0008021) |
1.0 | 17.0 | GO:0042599 | lamellar body(GO:0042599) |
1.0 | 6.9 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
1.0 | 12.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.0 | 11.5 | GO:0005915 | zonula adherens(GO:0005915) |
0.9 | 2.8 | GO:0033263 | CORVET complex(GO:0033263) |
0.9 | 0.9 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.9 | 15.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.9 | 6.4 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.9 | 23.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.9 | 2.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.9 | 4.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.9 | 18.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.9 | 4.5 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.9 | 3.6 | GO:0071920 | cleavage body(GO:0071920) |
0.9 | 5.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.9 | 54.2 | GO:0043679 | axon terminus(GO:0043679) |
0.9 | 11.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.9 | 99.8 | GO:0005604 | basement membrane(GO:0005604) |
0.9 | 0.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.8 | 9.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.8 | 2.5 | GO:0034456 | CURI complex(GO:0032545) UTP-C complex(GO:0034456) |
0.8 | 7.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.8 | 1.7 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.8 | 3.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.8 | 4.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.8 | 24.7 | GO:0071565 | nBAF complex(GO:0071565) |
0.8 | 1.6 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.8 | 3.2 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
0.8 | 90.0 | GO:0005901 | caveola(GO:0005901) |
0.8 | 5.6 | GO:0034706 | sodium channel complex(GO:0034706) |
0.8 | 6.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.8 | 6.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.8 | 3.9 | GO:0071817 | MMXD complex(GO:0071817) |
0.8 | 2.3 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.8 | 6.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.8 | 1.5 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.8 | 10.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.8 | 13.5 | GO:0005776 | autophagosome(GO:0005776) |
0.7 | 1.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.7 | 9.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.7 | 17.7 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.7 | 2.2 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.7 | 9.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.7 | 50.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.7 | 46.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.7 | 5.7 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.7 | 4.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.7 | 1.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.7 | 2.1 | GO:1990630 | IRE1-RACK1-PP2A complex(GO:1990630) |
0.7 | 0.7 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
0.7 | 21.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.7 | 4.1 | GO:1990393 | 3M complex(GO:1990393) |
0.7 | 5.4 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.7 | 2.0 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.7 | 7.4 | GO:0044754 | autolysosome(GO:0044754) |
0.7 | 17.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.7 | 7.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.7 | 9.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.7 | 4.6 | GO:0070695 | FHF complex(GO:0070695) |
0.7 | 3.9 | GO:0070820 | tertiary granule(GO:0070820) |
0.6 | 1.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.6 | 3.9 | GO:0070826 | paraferritin complex(GO:0070826) |
0.6 | 4.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.6 | 8.3 | GO:0071437 | invadopodium(GO:0071437) |
0.6 | 15.8 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.6 | 3.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.6 | 3.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.6 | 120.5 | GO:0043209 | myelin sheath(GO:0043209) |
0.6 | 3.7 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.6 | 0.6 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.6 | 7.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.6 | 2.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.6 | 5.8 | GO:0034709 | methylosome(GO:0034709) |
0.6 | 18.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.6 | 1.7 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.6 | 3.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.6 | 57.3 | GO:0043204 | perikaryon(GO:0043204) |
0.6 | 3.4 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.6 | 3.4 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.6 | 2.8 | GO:0043224 | Cul7-RING ubiquitin ligase complex(GO:0031467) nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.6 | 2.8 | GO:0032584 | growth cone membrane(GO:0032584) |
0.6 | 1.7 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.6 | 6.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.6 | 0.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.6 | 44.9 | GO:0034705 | potassium channel complex(GO:0034705) |
0.6 | 4.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.6 | 0.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.6 | 3.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.5 | 9.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.5 | 2.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.5 | 112.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.5 | 1.6 | GO:0034066 | RIC1-RGP1 guanyl-nucleotide exchange factor complex(GO:0034066) |
0.5 | 5.8 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.5 | 7.4 | GO:0044298 | cell body membrane(GO:0044298) |
0.5 | 7.9 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.5 | 3.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.5 | 1.6 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.5 | 2.1 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
0.5 | 2.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.5 | 4.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.5 | 3.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.5 | 3.0 | GO:0030897 | HOPS complex(GO:0030897) |
0.5 | 10.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.5 | 21.7 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.5 | 3.0 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.5 | 1.5 | GO:0070992 | translation initiation complex(GO:0070992) |
0.5 | 10.7 | GO:0030008 | TRAPP complex(GO:0030008) |
0.5 | 1.5 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.5 | 71.2 | GO:0099572 | postsynaptic specialization(GO:0099572) |
0.5 | 1.9 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.5 | 1.9 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.5 | 4.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.5 | 16.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.5 | 12.1 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.5 | 1.9 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.5 | 11.0 | GO:0005922 | connexon complex(GO:0005922) |
0.5 | 10.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.5 | 8.2 | GO:0000145 | exocyst(GO:0000145) |
0.5 | 2.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.5 | 3.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.5 | 3.6 | GO:0070847 | core mediator complex(GO:0070847) |
0.4 | 4.9 | GO:0031931 | TORC1 complex(GO:0031931) |
0.4 | 1.8 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.4 | 87.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.4 | 0.8 | GO:0042583 | chromaffin granule(GO:0042583) |
0.4 | 16.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.4 | 0.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.4 | 4.5 | GO:0031082 | BLOC complex(GO:0031082) |
0.4 | 19.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.4 | 4.0 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.4 | 2.0 | GO:1990745 | EARP complex(GO:1990745) |
0.4 | 1.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.4 | 4.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.4 | 1.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.4 | 31.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.4 | 76.1 | GO:0005769 | early endosome(GO:0005769) |
0.4 | 8.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.4 | 4.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.4 | 1.2 | GO:0097637 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
0.4 | 6.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 3.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.4 | 2.6 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.4 | 0.4 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.4 | 2.6 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.4 | 0.7 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.4 | 7.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.4 | 1.5 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.4 | 1.5 | GO:0071797 | LUBAC complex(GO:0071797) |
0.4 | 1.5 | GO:0043203 | axon hillock(GO:0043203) |
0.4 | 2.2 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.4 | 1.1 | GO:0034455 | t-UTP complex(GO:0034455) |
0.4 | 41.0 | GO:0005770 | late endosome(GO:0005770) |
0.4 | 2.9 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 98.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.4 | 1.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.4 | 23.6 | GO:0030133 | transport vesicle(GO:0030133) |
0.4 | 1.1 | GO:0090537 | CERF complex(GO:0090537) |
0.4 | 2.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 1.8 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 26.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.3 | 4.2 | GO:0030315 | T-tubule(GO:0030315) |
0.3 | 4.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.3 | 143.8 | GO:0005768 | endosome(GO:0005768) |
0.3 | 1.0 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.3 | 3.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 0.7 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.3 | 0.7 | GO:0097441 | basilar dendrite(GO:0097441) |
0.3 | 23.0 | GO:0030027 | lamellipodium(GO:0030027) |
0.3 | 1.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.3 | 14.6 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.3 | 1.0 | GO:0044292 | dendrite terminus(GO:0044292) |
0.3 | 1.3 | GO:0097447 | dendritic tree(GO:0097447) |
0.3 | 13.3 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.3 | 1.6 | GO:0089701 | U2AF(GO:0089701) |
0.3 | 3.8 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.3 | 15.8 | GO:0032420 | stereocilium(GO:0032420) |
0.3 | 4.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 0.9 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.3 | 15.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.3 | 2.8 | GO:0070552 | BRISC complex(GO:0070552) |
0.3 | 24.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 75.5 | GO:0045202 | synapse(GO:0045202) |
0.3 | 11.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.3 | 12.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.3 | 58.9 | GO:0000139 | Golgi membrane(GO:0000139) |
0.3 | 1.2 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.3 | 2.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 31.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.3 | 35.4 | GO:0031012 | extracellular matrix(GO:0031012) |
0.3 | 5.5 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.3 | 0.3 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.3 | 1.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.3 | 4.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.3 | 1.3 | GO:0035363 | histone locus body(GO:0035363) |
0.3 | 19.8 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 2.6 | GO:0005921 | gap junction(GO:0005921) |
0.3 | 262.8 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.3 | 1.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 5.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 14.3 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.2 | 43.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 21.2 | GO:0005938 | cell cortex(GO:0005938) |
0.2 | 0.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 3.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 1.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 11.0 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 3.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 1.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 1.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.2 | 0.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 1.9 | GO:0048500 | signal recognition particle(GO:0048500) |
0.2 | 8.2 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 1.0 | GO:0070449 | elongin complex(GO:0070449) |
0.2 | 1.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 0.6 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.2 | 7.9 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.2 | 0.6 | GO:0018444 | translation release factor complex(GO:0018444) |
0.2 | 2.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.8 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 0.6 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.2 | 1.4 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 855.1 | GO:0016021 | integral component of membrane(GO:0016021) |
0.2 | 0.6 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.2 | 1.0 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 0.6 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.2 | 0.6 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.2 | 0.6 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 0.9 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.2 | 3.0 | GO:0002102 | podosome(GO:0002102) |
0.2 | 2.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 1.2 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 1.6 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 1.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 0.3 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 231.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 2.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 3.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 2.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.6 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.1 | 1.0 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.9 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.1 | 1.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 17.0 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 1.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.7 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 1.9 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.7 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.6 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.7 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 4.5 | GO:0030424 | axon(GO:0030424) |
0.1 | 0.8 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 1.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 1.0 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.1 | 1.5 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.2 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 1.6 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.2 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.0 | 1.0 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.0 | 0.1 | GO:0042611 | MHC protein complex(GO:0042611) |
0.0 | 0.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.3 | GO:1990777 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.0 | 1.4 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.0 | 20.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
6.2 | 18.7 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
6.1 | 24.4 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
5.7 | 22.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
5.6 | 39.4 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
5.4 | 37.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
5.2 | 15.6 | GO:0010428 | methyl-CpNpG binding(GO:0010428) |
4.8 | 48.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
4.3 | 12.9 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
4.3 | 21.3 | GO:0097001 | ceramide binding(GO:0097001) |
4.1 | 49.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
4.0 | 32.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
4.0 | 36.3 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
4.0 | 20.0 | GO:0099609 | microtubule lateral binding(GO:0099609) |
4.0 | 12.0 | GO:0001565 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
3.9 | 15.5 | GO:0004736 | pyruvate carboxylase activity(GO:0004736) |
3.9 | 23.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
3.8 | 15.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
3.7 | 22.0 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
3.6 | 10.7 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
3.5 | 10.4 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
3.5 | 10.4 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
3.4 | 31.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
3.4 | 10.3 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
3.4 | 13.7 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
3.2 | 9.6 | GO:0004001 | adenosine kinase activity(GO:0004001) |
3.2 | 9.5 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
3.1 | 12.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
3.1 | 9.3 | GO:0035939 | microsatellite binding(GO:0035939) |
3.0 | 9.1 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
3.0 | 9.0 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
3.0 | 44.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
2.9 | 8.7 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
2.9 | 11.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
2.9 | 11.6 | GO:0045183 | translation factor activity, non-nucleic acid binding(GO:0045183) |
2.9 | 17.3 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
2.9 | 11.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
2.8 | 31.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
2.8 | 11.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
2.8 | 8.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
2.8 | 11.2 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
2.8 | 8.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
2.8 | 8.3 | GO:0047661 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
2.7 | 35.7 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
2.7 | 8.2 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
2.7 | 10.8 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
2.7 | 80.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
2.7 | 8.0 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
2.7 | 10.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
2.7 | 8.0 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
2.6 | 13.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
2.6 | 20.9 | GO:0043237 | laminin-1 binding(GO:0043237) |
2.6 | 10.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
2.5 | 15.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
2.5 | 12.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.5 | 12.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
2.5 | 7.4 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
2.4 | 22.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.4 | 9.6 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
2.4 | 14.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
2.3 | 15.9 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
2.3 | 22.6 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
2.3 | 9.0 | GO:0042806 | fucose binding(GO:0042806) |
2.2 | 8.9 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
2.2 | 17.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
2.2 | 6.6 | GO:0008119 | thiopurine S-methyltransferase activity(GO:0008119) |
2.2 | 6.5 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
2.1 | 6.3 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
2.1 | 6.2 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
2.1 | 12.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
2.1 | 6.2 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
2.1 | 10.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
2.1 | 16.5 | GO:0008410 | CoA-transferase activity(GO:0008410) |
2.1 | 10.3 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
2.1 | 28.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
2.0 | 8.2 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
2.0 | 10.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
2.0 | 20.2 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
2.0 | 10.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
2.0 | 14.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
2.0 | 8.0 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
2.0 | 8.0 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
2.0 | 19.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
2.0 | 9.9 | GO:0048495 | Roundabout binding(GO:0048495) |
2.0 | 148.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
1.9 | 7.7 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
1.9 | 24.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
1.9 | 5.7 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
1.9 | 13.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.9 | 7.5 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
1.9 | 5.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
1.9 | 5.6 | GO:0005148 | prolactin receptor binding(GO:0005148) |
1.9 | 7.5 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
1.9 | 9.3 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.8 | 27.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
1.8 | 14.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.8 | 11.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
1.8 | 9.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.8 | 27.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.8 | 10.9 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
1.8 | 10.9 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.8 | 16.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
1.8 | 12.6 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
1.8 | 10.8 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.8 | 7.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.8 | 12.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.8 | 5.3 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
1.7 | 6.9 | GO:0004096 | catalase activity(GO:0004096) |
1.7 | 6.9 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
1.7 | 11.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.7 | 5.1 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
1.7 | 26.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
1.7 | 5.0 | GO:0016034 | maleylacetoacetate isomerase activity(GO:0016034) |
1.7 | 10.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
1.7 | 8.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.7 | 16.6 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
1.7 | 18.2 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
1.6 | 8.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.6 | 6.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.6 | 3.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
1.6 | 25.9 | GO:0038191 | neuropilin binding(GO:0038191) |
1.6 | 9.6 | GO:0035671 | enone reductase activity(GO:0035671) |
1.6 | 6.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
1.6 | 6.3 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
1.6 | 7.9 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.6 | 4.7 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
1.6 | 6.2 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
1.6 | 6.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
1.5 | 1.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.5 | 17.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.5 | 4.6 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
1.5 | 1.5 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
1.5 | 16.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.5 | 7.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.5 | 18.1 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
1.5 | 7.5 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
1.5 | 4.5 | GO:0002061 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) |
1.5 | 7.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
1.5 | 4.5 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
1.5 | 4.4 | GO:0004493 | methylmalonyl-CoA epimerase activity(GO:0004493) |
1.5 | 19.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.5 | 8.9 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.5 | 13.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.5 | 17.6 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
1.5 | 10.2 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
1.5 | 14.6 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
1.5 | 16.0 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
1.4 | 28.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.4 | 7.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.4 | 43.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
1.4 | 14.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.4 | 38.3 | GO:0031489 | myosin V binding(GO:0031489) |
1.4 | 21.3 | GO:0005522 | profilin binding(GO:0005522) |
1.4 | 11.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.4 | 7.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.4 | 12.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.4 | 11.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.4 | 5.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
1.4 | 4.1 | GO:0008396 | oxysterol 7-alpha-hydroxylase activity(GO:0008396) |
1.4 | 13.7 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
1.4 | 4.1 | GO:0036004 | GAF domain binding(GO:0036004) |
1.4 | 5.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.4 | 16.4 | GO:0071253 | connexin binding(GO:0071253) |
1.4 | 8.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
1.3 | 5.4 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
1.3 | 4.0 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
1.3 | 21.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
1.3 | 9.3 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
1.3 | 15.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.3 | 5.2 | GO:0003883 | CTP synthase activity(GO:0003883) |
1.3 | 5.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
1.3 | 6.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.3 | 14.1 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
1.3 | 5.1 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
1.3 | 10.2 | GO:0010851 | cyclase regulator activity(GO:0010851) |
1.3 | 111.7 | GO:0048365 | Rac GTPase binding(GO:0048365) |
1.3 | 3.8 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
1.2 | 6.2 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
1.2 | 8.7 | GO:0045545 | syndecan binding(GO:0045545) |
1.2 | 1.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
1.2 | 5.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.2 | 6.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.2 | 1.2 | GO:0048030 | disaccharide binding(GO:0048030) |
1.2 | 3.7 | GO:0004962 | endothelin receptor activity(GO:0004962) |
1.2 | 6.2 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
1.2 | 3.7 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
1.2 | 6.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.2 | 3.7 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
1.2 | 6.1 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
1.2 | 3.7 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
1.2 | 6.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
1.2 | 1.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.2 | 10.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
1.2 | 7.2 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
1.2 | 4.8 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
1.2 | 9.6 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.2 | 10.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.2 | 3.6 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.2 | 1.2 | GO:0048185 | activin binding(GO:0048185) |
1.2 | 3.5 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
1.2 | 3.5 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
1.2 | 3.5 | GO:0004133 | glycogen debranching enzyme activity(GO:0004133) 4-alpha-glucanotransferase activity(GO:0004134) amylo-alpha-1,6-glucosidase activity(GO:0004135) |
1.2 | 1.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
1.2 | 1.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
1.2 | 21.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.2 | 3.5 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
1.2 | 9.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.2 | 11.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.2 | 5.8 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
1.2 | 3.5 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
1.1 | 3.4 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
1.1 | 4.6 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.1 | 1.1 | GO:0030911 | TPR domain binding(GO:0030911) |
1.1 | 17.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
1.1 | 6.8 | GO:1903136 | cuprous ion binding(GO:1903136) |
1.1 | 3.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.1 | 13.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.1 | 11.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
1.1 | 11.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.1 | 37.1 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
1.1 | 29.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
1.1 | 72.5 | GO:0030276 | clathrin binding(GO:0030276) |
1.1 | 4.5 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
1.1 | 3.3 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
1.1 | 6.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
1.1 | 4.4 | GO:0005118 | sevenless binding(GO:0005118) |
1.1 | 3.3 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
1.1 | 3.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
1.1 | 7.7 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
1.1 | 3.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.1 | 2.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.1 | 5.4 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
1.1 | 34.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
1.1 | 6.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.1 | 8.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.1 | 36.5 | GO:0043236 | laminin binding(GO:0043236) |
1.1 | 7.5 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
1.1 | 11.7 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
1.1 | 14.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
1.1 | 36.1 | GO:0035254 | glutamate receptor binding(GO:0035254) |
1.1 | 3.2 | GO:1990931 | oxidative DNA demethylase activity(GO:0035516) RNA N6-methyladenosine dioxygenase activity(GO:1990931) |
1.1 | 3.2 | GO:0070279 | vitamin B6 binding(GO:0070279) |
1.1 | 4.2 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
1.1 | 8.4 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
1.1 | 5.3 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
1.1 | 3.2 | GO:0030984 | kininogen binding(GO:0030984) |
1.0 | 3.1 | GO:0001847 | opsonin receptor activity(GO:0001847) |
1.0 | 4.2 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
1.0 | 7.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
1.0 | 14.5 | GO:1990459 | transferrin receptor binding(GO:1990459) |
1.0 | 3.1 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
1.0 | 4.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
1.0 | 7.2 | GO:0001851 | complement component C3b binding(GO:0001851) |
1.0 | 3.1 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
1.0 | 6.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.0 | 18.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
1.0 | 145.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
1.0 | 1.0 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
1.0 | 6.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.0 | 6.1 | GO:0043559 | insulin binding(GO:0043559) |
1.0 | 32.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
1.0 | 5.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
1.0 | 9.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
1.0 | 1.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
1.0 | 6.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.0 | 6.0 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
1.0 | 21.8 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
1.0 | 3.0 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
1.0 | 3.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
1.0 | 24.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.0 | 10.9 | GO:0031419 | cobalamin binding(GO:0031419) |
1.0 | 3.0 | GO:0071820 | N-box binding(GO:0071820) |
1.0 | 21.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.0 | 3.9 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.0 | 7.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
1.0 | 3.9 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
1.0 | 15.4 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
1.0 | 2.9 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
1.0 | 5.7 | GO:0004359 | glutaminase activity(GO:0004359) |
1.0 | 4.8 | GO:0016615 | malate dehydrogenase activity(GO:0016615) L-malate dehydrogenase activity(GO:0030060) |
1.0 | 13.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.9 | 9.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.9 | 17.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.9 | 4.7 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.9 | 4.7 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.9 | 40.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.9 | 11.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.9 | 0.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.9 | 2.8 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.9 | 5.5 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.9 | 3.7 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.9 | 69.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.9 | 2.7 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.9 | 8.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.9 | 6.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.9 | 4.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.9 | 5.4 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.9 | 34.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.9 | 5.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.9 | 2.7 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.9 | 1.8 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.9 | 0.9 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.9 | 2.7 | GO:0016213 | linoleoyl-CoA desaturase activity(GO:0016213) |
0.9 | 7.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.9 | 8.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.9 | 2.6 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.9 | 18.9 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.9 | 6.9 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.8 | 5.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.8 | 4.2 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.8 | 4.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.8 | 8.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.8 | 15.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.8 | 71.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.8 | 18.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.8 | 14.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.8 | 5.8 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.8 | 31.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.8 | 5.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.8 | 1.6 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.8 | 9.0 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.8 | 4.1 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.8 | 1.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.8 | 16.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.8 | 2.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.8 | 4.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.8 | 1.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.8 | 4.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.8 | 117.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.8 | 2.4 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.8 | 8.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.8 | 8.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.8 | 5.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.8 | 3.2 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.8 | 3.9 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.8 | 11.8 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.8 | 5.5 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.8 | 26.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.8 | 5.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.8 | 3.9 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.8 | 29.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.8 | 2.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.8 | 47.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.8 | 2.3 | GO:0005135 | interleukin-3 receptor binding(GO:0005135) |
0.8 | 3.0 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.8 | 1.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.8 | 3.8 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.8 | 5.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.8 | 1.5 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.7 | 3.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.7 | 4.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.7 | 7.5 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.7 | 3.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.7 | 6.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.7 | 8.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.7 | 8.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.7 | 2.2 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.7 | 33.2 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.7 | 0.7 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.7 | 23.5 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) |
0.7 | 6.6 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.7 | 2.2 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
0.7 | 4.4 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.7 | 2.9 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.7 | 17.4 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.7 | 2.9 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.7 | 2.2 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.7 | 79.0 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.7 | 17.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.7 | 19.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.7 | 0.7 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.7 | 2.1 | GO:0047291 | lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
0.7 | 2.8 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.7 | 2.8 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.7 | 2.1 | GO:0070025 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitric oxide binding(GO:0070026) |
0.7 | 5.6 | GO:0015099 | nickel cation transmembrane transporter activity(GO:0015099) |
0.7 | 4.9 | GO:0034431 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.7 | 2.1 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) mechanically-gated potassium channel activity(GO:0098782) |
0.7 | 4.9 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.7 | 7.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.7 | 16.7 | GO:0031005 | filamin binding(GO:0031005) |
0.7 | 10.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.7 | 5.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.7 | 1.4 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.7 | 17.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.7 | 2.0 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.7 | 0.7 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.7 | 3.3 | GO:1990188 | euchromatin binding(GO:1990188) |
0.7 | 2.6 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.7 | 5.9 | GO:0046790 | virion binding(GO:0046790) |
0.7 | 2.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.7 | 28.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.7 | 11.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.6 | 3.9 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.6 | 6.5 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.6 | 1.9 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.6 | 12.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.6 | 49.0 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.6 | 3.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.6 | 3.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.6 | 0.6 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) chondroitin 4-sulfotransferase activity(GO:0047756) |
0.6 | 1.9 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.6 | 12.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.6 | 6.2 | GO:0016247 | channel regulator activity(GO:0016247) |
0.6 | 9.3 | GO:0070402 | NADPH binding(GO:0070402) |
0.6 | 2.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.6 | 11.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.6 | 22.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.6 | 2.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.6 | 8.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.6 | 1.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.6 | 1.8 | GO:0008456 | alpha-N-acetylgalactosaminidase activity(GO:0008456) |
0.6 | 1.8 | GO:0047651 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.6 | 3.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.6 | 2.4 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.6 | 39.8 | GO:0005518 | collagen binding(GO:0005518) |
0.6 | 0.6 | GO:0070538 | oleic acid binding(GO:0070538) |
0.6 | 1.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.6 | 1.8 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.6 | 2.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.6 | 2.3 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.6 | 4.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.6 | 13.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.6 | 0.6 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.6 | 1.7 | GO:0043532 | angiostatin binding(GO:0043532) |
0.6 | 1.7 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.6 | 18.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.6 | 8.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.6 | 1.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.6 | 6.9 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.6 | 4.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.6 | 2.9 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.6 | 13.0 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.6 | 2.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.6 | 3.9 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.6 | 1.7 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.6 | 1.7 | GO:0051861 | glycolipid binding(GO:0051861) |
0.5 | 10.9 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.5 | 6.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.5 | 1.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.5 | 2.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.5 | 13.4 | GO:0019905 | syntaxin binding(GO:0019905) |
0.5 | 1.6 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.5 | 1.6 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.5 | 4.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.5 | 1.6 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.5 | 62.4 | GO:0005178 | integrin binding(GO:0005178) |
0.5 | 16.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.5 | 6.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.5 | 2.0 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
0.5 | 2.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.5 | 2.0 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.5 | 3.0 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.5 | 19.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.5 | 1.5 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.5 | 7.0 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.5 | 2.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.5 | 2.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.5 | 8.0 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.5 | 9.9 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.5 | 3.5 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) steroid sulfotransferase activity(GO:0050294) |
0.5 | 3.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.5 | 2.0 | GO:0035276 | ethanol binding(GO:0035276) |
0.5 | 7.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.5 | 2.9 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.5 | 2.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.5 | 6.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.5 | 1.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.5 | 3.4 | GO:0032564 | dATP binding(GO:0032564) |
0.5 | 4.8 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.5 | 1.9 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.5 | 15.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.5 | 6.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.5 | 1.9 | GO:0016807 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
0.5 | 5.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.5 | 10.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.5 | 0.9 | GO:0038100 | nodal binding(GO:0038100) |
0.5 | 8.1 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.5 | 1.9 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.5 | 7.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.5 | 12.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.5 | 3.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.5 | 17.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.5 | 17.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.5 | 8.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.5 | 0.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.5 | 1.4 | GO:0015152 | glucose-6-phosphate transmembrane transporter activity(GO:0015152) |
0.5 | 1.8 | GO:0000010 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.5 | 4.6 | GO:0015288 | porin activity(GO:0015288) |
0.5 | 6.4 | GO:0071949 | FAD binding(GO:0071949) |
0.5 | 1.4 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
0.5 | 24.4 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.5 | 1.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.5 | 2.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.4 | 2.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.4 | 5.8 | GO:0070403 | NAD+ binding(GO:0070403) |
0.4 | 1.3 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.4 | 1.3 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.4 | 1.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.4 | 1.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.4 | 1.7 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
0.4 | 1.3 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.4 | 1.7 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.4 | 7.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.4 | 1.7 | GO:0070404 | NADH binding(GO:0070404) |
0.4 | 4.6 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.4 | 1.7 | GO:0001846 | opsonin binding(GO:0001846) |
0.4 | 4.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.4 | 1.7 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.4 | 23.5 | GO:0015485 | cholesterol binding(GO:0015485) |
0.4 | 1.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.4 | 1.6 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.4 | 4.5 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.4 | 1.2 | GO:0033971 | hydroxyisourate hydrolase activity(GO:0033971) |
0.4 | 1.2 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.4 | 2.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 1.2 | GO:0019002 | GMP binding(GO:0019002) |
0.4 | 3.6 | GO:0051378 | serotonin binding(GO:0051378) |
0.4 | 2.8 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.4 | 3.2 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.4 | 1.6 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.4 | 0.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.4 | 2.3 | GO:0035473 | lipase binding(GO:0035473) |
0.4 | 3.5 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.4 | 7.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.4 | 0.8 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.4 | 1.9 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 10.8 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.4 | 0.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.4 | 1.9 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.4 | 107.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.4 | 1.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.4 | 1.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.4 | 4.7 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.4 | 1.1 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.4 | 1.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.4 | 20.0 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.4 | 2.9 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.4 | 0.7 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.4 | 2.1 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.4 | 9.3 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.4 | 1.4 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.4 | 5.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.4 | 2.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 2.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.3 | 4.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.3 | 3.8 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.3 | 9.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 22.6 | GO:0005496 | steroid binding(GO:0005496) |
0.3 | 1.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.3 | 2.8 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 0.3 | GO:0003681 | bent DNA binding(GO:0003681) |
0.3 | 3.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 1.7 | GO:0008199 | ferric iron binding(GO:0008199) |
0.3 | 0.3 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.3 | 1.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 2.0 | GO:0004111 | creatine kinase activity(GO:0004111) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.3 | 3.1 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.3 | 3.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 3.0 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 12.0 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.3 | 1.0 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.3 | 2.9 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.3 | 1.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 1.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 2.6 | GO:0042285 | xylosyltransferase activity(GO:0042285) |
0.3 | 4.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.3 | 7.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.3 | 4.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 80.7 | GO:0008017 | microtubule binding(GO:0008017) |
0.3 | 9.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 0.6 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.3 | 5.1 | GO:0019841 | retinol binding(GO:0019841) |
0.3 | 6.1 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.3 | 1.6 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.3 | 2.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 1.9 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.3 | 0.9 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.3 | 1.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 1.6 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.3 | 5.3 | GO:0030552 | cAMP binding(GO:0030552) |
0.3 | 0.3 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.3 | 2.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 1.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.3 | 8.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 1.5 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.3 | 8.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.3 | 6.7 | GO:0008483 | transaminase activity(GO:0008483) |
0.3 | 0.9 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.3 | 1.8 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.3 | 6.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 1.5 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 9.0 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 2.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 0.9 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 1.2 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.3 | 1.8 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.3 | 0.6 | GO:1901474 | L-histidine transmembrane transporter activity(GO:0005290) azole transmembrane transporter activity(GO:1901474) |
0.3 | 0.9 | GO:0016492 | G-protein coupled neurotensin receptor activity(GO:0016492) |
0.3 | 4.3 | GO:0031402 | sodium ion binding(GO:0031402) |
0.3 | 1.4 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 1.4 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.3 | 1.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.3 | 1.4 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.3 | 1.7 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.3 | 28.0 | GO:0008201 | heparin binding(GO:0008201) |
0.3 | 11.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 1.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 4.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 2.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.3 | 8.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.3 | 0.8 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.3 | 5.1 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.3 | 15.8 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.3 | 1.9 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 0.8 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.3 | 5.1 | GO:0000149 | SNARE binding(GO:0000149) |
0.3 | 1.1 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.3 | 6.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.3 | 2.1 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.3 | 17.3 | GO:0044325 | ion channel binding(GO:0044325) |
0.3 | 2.9 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.3 | 1.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.3 | 2.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 0.8 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.3 | 1.0 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.3 | 0.8 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.3 | 1.8 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.3 | 1.0 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.2 | 10.5 | GO:0015108 | chloride transmembrane transporter activity(GO:0015108) |
0.2 | 2.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 3.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 2.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 3.1 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.2 | 1.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 1.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 0.7 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.2 | 0.7 | GO:0004067 | asparaginase activity(GO:0004067) |
0.2 | 0.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 0.7 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.2 | 2.0 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 0.9 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.2 | 108.8 | GO:0005509 | calcium ion binding(GO:0005509) |
0.2 | 3.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 10.9 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 2.8 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 1.7 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 0.6 | GO:0003868 | 4-hydroxyphenylpyruvate dioxygenase activity(GO:0003868) |
0.2 | 1.0 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.2 | 3.9 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 1.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 0.8 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.2 | 1.2 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.2 | 0.4 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.2 | 0.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 5.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 0.8 | GO:0051381 | histamine binding(GO:0051381) |
0.2 | 1.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 4.0 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.2 | 3.0 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.2 | 4.9 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.2 | 3.6 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.2 | 1.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.4 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 0.4 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.2 | 5.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 0.5 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.2 | 0.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 1.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 1.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.5 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 0.9 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 0.7 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 5.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.2 | 1.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.2 | 0.2 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.2 | 0.5 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 1.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 1.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 3.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 0.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 2.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 1.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 5.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 2.5 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.2 | 3.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 1.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.2 | 14.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 0.6 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.2 | 0.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 46.6 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 0.9 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 0.9 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 3.2 | GO:0008252 | nucleotidase activity(GO:0008252) 5'-nucleotidase activity(GO:0008253) |
0.1 | 1.8 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 1.3 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 1.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 43.5 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 0.8 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 11.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 1.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.8 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 16.9 | GO:0005543 | phospholipid binding(GO:0005543) |
0.1 | 3.6 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.1 | 3.0 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 1.6 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.4 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 3.0 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 1.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.5 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 0.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.4 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 9.4 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.9 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 1.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 1.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.6 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.1 | 4.4 | GO:0020037 | heme binding(GO:0020037) |
0.1 | 1.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 1.7 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 1.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 1.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 1.6 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.4 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.4 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.1 | 1.8 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 1.7 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 0.7 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.4 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.9 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.4 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 0.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 8.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 1.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 6.4 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 1.2 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.9 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 1.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.5 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.1 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.1 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 1.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.2 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
0.1 | 0.2 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.3 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.1 | 0.4 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 1.0 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.4 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.2 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.3 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.2 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.2 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.3 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 0.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.2 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
0.0 | 0.2 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.6 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.3 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 1.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.1 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.7 | GO:0015631 | tubulin binding(GO:0015631) |
0.0 | 0.0 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.0 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.0 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.1 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.3 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 5.4 | PID IFNG PATHWAY | IFN-gamma pathway |
2.7 | 5.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
2.5 | 2.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
2.3 | 9.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
2.2 | 21.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
1.9 | 17.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.7 | 37.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.6 | 61.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.5 | 19.1 | PID ALK2 PATHWAY | ALK2 signaling events |
1.3 | 70.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
1.3 | 6.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
1.2 | 17.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.2 | 36.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.2 | 19.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
1.2 | 66.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.2 | 72.6 | PID REELIN PATHWAY | Reelin signaling pathway |
1.1 | 37.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.1 | 34.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.1 | 18.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
1.1 | 12.7 | PID S1P S1P2 PATHWAY | S1P2 pathway |
1.1 | 40.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
1.0 | 18.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.0 | 26.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.0 | 37.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
1.0 | 8.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
1.0 | 66.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.9 | 31.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.9 | 15.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.9 | 4.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.9 | 23.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.9 | 22.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.8 | 7.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.8 | 53.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.8 | 18.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.8 | 22.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.8 | 18.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.8 | 2.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.8 | 29.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.8 | 10.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.7 | 7.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.7 | 138.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.7 | 147.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.7 | 11.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.7 | 7.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.6 | 13.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.6 | 3.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.6 | 3.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.6 | 7.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.6 | 17.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.6 | 6.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.6 | 31.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.6 | 32.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.5 | 12.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.5 | 11.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.5 | 38.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.5 | 7.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.5 | 10.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.5 | 11.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.4 | 6.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 2.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.4 | 5.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.4 | 7.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.4 | 18.9 | PID BMP PATHWAY | BMP receptor signaling |
0.4 | 4.9 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.4 | 21.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.4 | 9.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.4 | 9.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 0.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 104.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.4 | 17.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.4 | 13.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.4 | 0.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.4 | 4.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 10.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.4 | 3.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 8.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 6.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.3 | 20.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 5.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 6.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 1.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 0.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 6.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 0.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 1.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 6.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 6.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 5.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 6.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 8.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 11.6 | PID SHP2 PATHWAY | SHP2 signaling |
0.3 | 2.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 1.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.3 | 5.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.3 | 4.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 3.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.3 | 1.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 14.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 5.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 1.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 6.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 8.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 0.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 3.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 6.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 17.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 4.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 6.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 2.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 9.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 3.6 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 9.1 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 12.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 7.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 1.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 1.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 15.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 1.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 4.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 2.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 2.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.0 | 101.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
4.4 | 4.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
3.5 | 6.9 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
2.8 | 33.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
2.3 | 22.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
2.1 | 65.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
2.1 | 41.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
2.0 | 19.7 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
2.0 | 47.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.9 | 26.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
1.8 | 88.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
1.8 | 45.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
1.7 | 21.8 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.7 | 26.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.6 | 56.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
1.6 | 32.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.5 | 9.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
1.5 | 47.8 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
1.4 | 28.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.4 | 8.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
1.4 | 6.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
1.4 | 16.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
1.3 | 63.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.3 | 83.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.3 | 63.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.3 | 43.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
1.3 | 9.0 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.2 | 17.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.2 | 17.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
1.1 | 25.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.1 | 17.9 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
1.1 | 1.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
1.1 | 68.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.1 | 38.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.0 | 17.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
1.0 | 4.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
1.0 | 32.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
1.0 | 13.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.9 | 1.8 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.9 | 2.7 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.9 | 21.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.9 | 16.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.9 | 42.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.9 | 7.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.9 | 0.9 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.9 | 14.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.9 | 17.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.9 | 11.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.9 | 17.2 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.8 | 16.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.8 | 18.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.8 | 18.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.8 | 18.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.8 | 3.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.8 | 34.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.8 | 15.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.8 | 8.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.8 | 29.6 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.7 | 24.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.7 | 12.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.7 | 24.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.7 | 19.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.7 | 2.7 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.7 | 63.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.7 | 13.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.6 | 9.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.6 | 6.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.6 | 8.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.6 | 14.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.6 | 27.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.6 | 80.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.6 | 16.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.6 | 2.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.6 | 5.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.6 | 7.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.6 | 10.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.6 | 1.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.5 | 75.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.5 | 52.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.5 | 2.7 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.5 | 14.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.5 | 7.4 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.5 | 9.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.5 | 11.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.5 | 16.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.5 | 13.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.5 | 3.9 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.5 | 1.5 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.5 | 16.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.5 | 1.9 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.5 | 5.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.5 | 9.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.5 | 17.5 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.5 | 8.2 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.5 | 15.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.5 | 10.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.4 | 5.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.4 | 5.7 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.4 | 1.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.4 | 8.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.4 | 19.5 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.4 | 9.3 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.4 | 3.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.4 | 5.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.4 | 5.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.4 | 25.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.4 | 3.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 27.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.4 | 6.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 6.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 14.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.4 | 1.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.4 | 1.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 8.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.4 | 6.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.4 | 6.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.4 | 1.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.4 | 56.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.4 | 5.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.4 | 7.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 3.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.4 | 8.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 11.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 4.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 2.7 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.3 | 5.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 2.9 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.3 | 10.3 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.3 | 16.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 28.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 7.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 4.7 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.3 | 6.0 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.3 | 47.5 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.3 | 2.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.3 | 17.1 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.3 | 2.0 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.3 | 11.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.3 | 10.6 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.3 | 12.8 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.3 | 5.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 0.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 12.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.3 | 2.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 0.5 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.2 | 3.9 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 31.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.2 | 2.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 3.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 24.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 7.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 5.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 6.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 13.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.2 | 1.9 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 2.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 0.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 0.6 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.2 | 3.1 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.2 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 4.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 9.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 5.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.2 | 3.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 2.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 12.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.2 | 0.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 2.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 1.4 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.2 | 2.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 2.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 5.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 4.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 1.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 1.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 9.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.4 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 1.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 4.3 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 3.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 2.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 2.5 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 0.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 5.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 0.6 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 1.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 4.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 1.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.3 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 1.5 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.0 | 1.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 1.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 1.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |